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Editorial

Changes

Leanne Tran, Editor-in-Chief

If we look at the field of obstetrics and gynecology, the feature topic of this issue, and compare it to even ten years ago, we
would find that in terms of the practice structure, technology and
lifestyle, there have been significant changes. These changes are
indicative of the way that medicine in general is progressing. As
stated by Dr. Paul Bernstein, an obstetrician and gynecologist at
Mount Sinai Hospital in Toronto, "I personally think that [obstetrics and gynecology] will evolve into more sub-specialization,
perhaps into surgical and non-surgical aspects. It would be practical to have streaming, as that would provide focus and improve
resources for new clinicians" . Upon reading this Profiles
Interview, I noted that this trend is not isolated to obstetrics and
gynecology but holds true for all of medicine. There is a noticeable shift of medicine towards greater specialization and focus on
individual interests whether one is a family physician, an internist
or a surgeon. This is inevitable; as we progress through medical
school, postgraduate training, independent practice and yes, life,
we are exposed to different ideas and people that shape our interests. Similarly, this issue of the UWOMJ is filled with a range of
exciting topics that include pregnancy complications, technological developments, ethical debates, and psychosocial perspectives.
In particular, I would like to draw your attention to an article
written by Dr. Gideon Koren, the Ivey Chair in Molecular
Toxicology at UWO. I encourage all of you to read this as it
serves as an introduction to the Motherisk Program that had its

inception at the Hospital for Sick Children in Toronto and is now
also operating at UWO. In addition to the start of the Motherisk
Program here at UWO, I am pleased to inform you that there have
been major developments to UWO's Global Health curriculum
since the publication of the last issue of the journal. The Joint
issue editorial entitled Physicians and Peace: Promoting Peace by
Pursuing Health spoke about a new academic discipline, "Peace
Through Health". Research has shown that health initiatives can
not only foster health in a region of conflict but peace as well.
Given the increasing awareness of the importance of global
health, it is only appropriate that the journal give an update on
UWO's contributions to this area. I believe that the piece The
Next Wave: Medical Education Without Borders is particularly
timely given the recent tsunami and the changes currently underway in academic and clinical medicine. The article emphasizes
the unique opportunity that we as health care workers have in
affecting the economic, political, legal and social network around
us and in the process, promote peace by pursuing health. Above
all, it reminds us to take a patient-centered, culturally sensitive,
and globally conscious approach to medicine. With this in mind,
I hope you enjoy reading this Obstetrics and Gynecology issue as
much as we, at the medical journal, have enjoyed putting it
together for you.
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Ethics

Prenatal Testing & Disability Rights: The Role of Healthcare Professionals

Tanya Raha, Meds 2006

Prenatal genetic diagnosis (PND) and pre-implantation genetic diagnosis (PGD) are becoming increasingly
avaiJable as options for parents-to-be. Despite the benefits of both procedures, several ethically troublesome
issues remain. In particular, disability rights advocates have expressed a number of concerns: the "expressivist" argument that such practices deem disabled individuals on a whole as unfit for living, that it accepts
and encourages parental attitudes of selectivity and intolerance, that PND-related decisions are often based
on misinformation or misconceptions, that it threatens the fair & equitable integration of disabled individuals as a part of our society and that it foretells a tendency towards eugenics. T here is a variety of opinions on
the use and practices of PND/PGD, both within and beyond the disabled community. As healthcare professionals who currently administer PND as a standard of care, our best response in addressing these concerns
lies in improving " informed" consent by securing and providing good, usable, complete information about life
with disability, especially as viewed by people who live lvith disability. It is also important to identify and work
on our own attitudinal biases, since we come from a biomedical model where there is often a tendency to see
disability firstly, if not exclusively, as something negative that should be ' fixed ' or 'eliminated'. Lastly, healthcare professionals are well-positioned and arguably obligated to take on an advocacy role to ensure that our
society is one which truly does hold the attitudes, services and support for parents to freely make their reproductive choice, whether that be to terminate a pregnancy or to have a potentially disabled child.

Over the past thirty years, prenatal genetic diagnosis (PND)
for serious medical conditions has become available and established as the standard o care for treating pregnant women in
Canada. PND in Canada currently includes the Maternal Serum
Screen (MSS) and ultrasound screening tests which are offered to
every pregnant woman, and if the woman is indicated to be at
high risk for fetal anomaly it can include the more invasive diagnostic tests of amniocentesis, chorionic villus sampling (CVS)
and further ultrasound.! ,2 More recently, with the development of
in vitro fertilization (IVF) techniques, the practice of pre-implantation genetic diagnosis (PGD) for serious medical conditions has
also come to the forefront.3 Both PND and PGD are used to test
for a variety of serious conditions: aneuploidy, neural tube
defects, Cystic Fibrosis (CF), Huntington 's Disease (HD), Tay
Sach 's disease, hemoglobinopathies and Muscular Dystrophy
(MD) all qualify, with other possible conditions tested if such risk
is indicated by a family history and/or carrier screening.l ,2
PND in combination with the subsequent options to terminate or carry to term a pregnancy has given us many benefits in
increasing client knowledge at times of reproductive decisionmaking, in reinforcing reproductive autonomy and choice, and in

4
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preventing serious medical conditions and the costs associated
with their treatrnent. 4 Yet for all its merits, PND still leaves us
grappling with challenging ethical and practical issues. While on
an individual level it seems positive to inform and reinforce the
reproductive autonomy of the parents and possibly prevent serious, debilitating medical conditions, decisions and actions such
as these invariably (if inadvertently) have impact and convey message at the public and political level. In particular with PND one
of the greatest concerns has been the impact on disa bled individual_s, ~enc~ we have what has been coined the "disability rights
obJeCtiOns to PND. One prong of this argument i the express_ivist argument, which contends that PND and the selective abortiOn that ~ften results to select against disabling traits express a
message to peop 1e w1o
1
hurtful
.
. attitude about, and
. send. a hurtful
..
llve wtth those same tratts.s Dtsabthty rights advocate Adri
~sch note~, "As wit~ discrimination more generally, with p~:
smgle tratt stands m for the whole, the trait obliterates the
whole ... nobody finds out about the rest. The tests send th
,
.
e message that there s no need to fmd out about the rest,"5 while S
.
notes, "The message at t he heart of wtdespread
abortiOn axton
h
· f PND · h
·
on t e
basts
o
ts t e greatest msult: some of us are "too flawed" in

our very DNA to exist; we are unworthy of being born ..."5
A second morally problematic area is the parental attitude
argument. According to it, using prenatal tests to select against
some traits indicates a problematic conception of and attitude
towards parenthood. Part of the argument is that PND is rooted in
a "fantasy and fallacy" that "parents can guarantee or create perfection".5 In addition, if prospective parents imagine that disability precludes everything else that could be wonderful about the
child, they have made biology destiny in the way that critics of the
medical model of disability consistently resist. Good parents will
care about raising whatever child they receive and about the relationship they will develop not about the traits the child bears. The
" selective mentality" revea led in paying attention to particular
traits supports a morally troubling conception of parenthood, a
preoccupation with what is trivial and an ignorance of what is
profound.5
A third criticism of PND and genetic termination is that it is
based on misinformation, and that decisions depend on a misunderstanding of what life with disability is like. There are many
widely accepted beliefs about what life with disability is like for
children with disabilities and their families . Most of these are not
based on data. They include assumptions that people with disabilities lead lives of relentless agony and frustration and that
most marriages break up under the strain of having a child with a
disability. Recent studies suggest, for example, that many members of the health professions view childhood disability as predominantly negative for children and their families, in contrast to
what research on the life satisfaction of people with disabilities
and their families has actually shown.6,7 One study with individuals with CF and HD corroborates this view, where in nearly all
twenty-four cases (except one) respondents reported their lives in
fairly positive terms, on many occasions expressing contentment
or happiness with the quality of life they experienced.8 Similarly,
three disability researchers analyzed empirical data on the impact
of children with disabilities on families . Their review, surprising
to many, concludes that the adaptational profiles of families that
have a child with a disability basically resemble those of families
that do not.9 Irrespective of whether a child is healthy or disabled,
on average, no one family has significantly more stress or adaptation challenges than the other.
Perhaps a most fundamental and irreconcilable disagreement
over misinformation is what having a disability is "really" like for
people: how much of the problem of disability is socially constructed? Nora Groce 's work establishes that much of what is difficult about having a disability stems from manifold facets of
society, from architecture to education to aesthetic preferences. In
choosing how to construct our societies, we "choose who will be
disabled", and if we were to choose differently, what's disabling
about what we now call disabilities would be largely eliminated.5
Indeed, healthcare professionals working in PND identify the
inability of our society to care appropriately for disabled children
as a major problem.IO It is not unreasonable, furthermore , to have
serious concerns that with the increasing use and accuracy of
PND and genetic terminations, disabled individuals - already a
minority - will become even smaller, less visible and possess less
political clout, resulting in even less accommodation and social
place in our society.

Tied perhaps to our inability to create an acceptable, equitable place for disabled individuals within our society is a growing intolerance for 'abnormal ' individuals. Healthcare professionals working in PND in France cited the request for abortion in the
case of minor anomalies such as Klinefelter or Turner syndromes,
cleft palate, or blindness as being the most frequent ethical dilemma that they were presented with, along with instances where
diagnosis and prognosis are uncertain .IO This foretells concerns
raised about PND progressing towards eugenics, an argument
often dismissed as the 's lippery slope'. The French obstetricians
and midwives commented, "The societal and medical values are
eugenic, there is more and more eugenic thinking" .I OThis highlights the importance of ' drawing lines in the sand' of what exactly constitutes a 'sufficiently serious' medical condition for PND
and possible genetic termination, and yet there appears to be no
easy way of achieving consensus on this issue among healthcare
professionals, policy makers or the disabled community itself.' 0,5
There is, to be sure, variation and ambivalence of opinion on
PND amongst the disabled community and those who have had
intimate experience with disabled individuals. For example, while
many disability rights critics of PND may suggest that the decision to terminate is based on inaccurate perceptions or a lack of
accurate information about what life is really like with a disability, a qualitative study amongst women carriers of X-linked conditions portrayed a different trend. The women who had grown up
with close relatives (i.e. brothers) affected with Duchenne 's
Muscular Dystrophy (DMD) and had first-hand experience of
what life is like with the condition were more certain and
unequivocal about their decision to terminate if PND indicated
such a condition for their fetus than those women who had not
had such intimate personal exposure to DMD. The latter women
were less certain and at least initially more ambivalent when considering the decision to terminate.'' Furthermore, some of the
women 'without personal experience' admitted they purposefully
avoided finding out too much information about the condition
they carried for fear of putting them off having children altogether, II thus indicating that more information is not always desired.
In another study, when asked about their views on PND and
choices, the majority of HD and CF patients indicated that PND
and the option of termination was a positive advantage. One CF
respondent went so far as to indicate that she would personally
elect to terminate her child if she knew it had CF or any other illnesses, "Because .. .! know what it's like. There's no way I would
bring a baby in this world". 8
So what should healthcare professionals do to address these
concerns? Perhaps the answer does not lie in eliminating PND but
by making its practice more sensitive and responsive to the objections raised. Perhaps most important, in accordance with the ethic
of genetic counseling, is that all genetics professionals must help
prospective parents give truly informed consent to receive testing
and equally must help patients reach truly informed decisions
about using test results. The first of these is by giving providers
access to good, usable information about what disability is really
like for children with disabilities and for their families. Education
about life with disability - as it is viewed by people who live with
disabilities - is still too rarely offered to those who deliver genetic information. Disability must become an important topic in the
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training of anyone who offers prenatal genetic tests, and should
ideally be integrated into care before a prenatal screening test,
prior to amniocentesis, and post-delivery of test results. If and
when clients indicate that they want information about disability,
it should be given- but what kind of information do they need?
According to the Down Syndrome Congress, prospective parents
who learn that their fetus has a disabling trait need to receive:
"a) information that seeks to dispel common misconceptions
about disability and present disability from the perspective of a
person with a disability; b) information on community based services for children with disabilities and their families as well as on
financial assistance programs; c) materials on special needs adoption; and d) a summary of major laws protecting the civil rights
of persons with disabilities. People with disabilities and parents
of people with disabilities should be available to talk with future
parents". s
There are PND programs that help prospective parents gather information about what life is like for families with children
who have disabilities. Yet some evidence suggests that there are
still physicians and genetic counselors who, for example, display
surprise or distress upon hearing that a woman wants to bring to
term a fetus identified as having a disability. This highlights the
importance of starting education "at home": if health professionals are to help individuals make truly informed decision, then
they, like everybody else in the "majority" community, must identify and overcome biases against people with disabilities.s Rather
than focusing on what is wrong with a disabled individual and
what disability prevents an individual from doing, as the medical
model often leads us to do, we need to focus on what the individual can do and on finding alternative ways for the individual to
enjoy the same types of life experiences (if modified) that the
"majority" do.
If healthcare professionals truly wish to offer and support the
widest possible range of reproductive options for their clients,
then they also have a responsibility to advocate for and to help
create a society where all individuals, able or ' di sabled ', are
accommodated and welcomed. As healthcare professionals often
have first-hand contact with di sabled individuals and their families as well as access to resources, they are well placed to be advocates for their clients on the individual level. On a population
level , they are al so well positioned to be the watchdog and vocal
advocate to ensure that social, financial , educational, medical and
political resources for the disabled community certainly do not
erode and continue to improve in quantity and quality. This
includes ensuring that research on successful prevention, treatment and management of various genetic conditions continues
apace and remains a high priority, despite the conceivably easier
path of simple eradication through PND.
But provision of resources is not enough. We must work to
change attitudes. For example, over the last three decades,
tremendous progress has been made in the medical and surgical
treatment of DS infants. Nationally in the US, a great deal of
resources are allocated to DS infants to improve their growth and
development. I 2 Yet the perception remains that the DS infant is
still not openly accepted by parents and society, as illustrated by
case reviews of parents receiving their DS infant in hospital. I 2 It
can be argued that health professionals have the responsibility to
6
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help make public attitudes more accepting of Down Syndrome.
Professionals should encourage social and community involvement of these children. National advocacy and service groups
should be contacted periodically to promote activities to enhance
public awareness.
Though PND and PGD may be here to stay as the "standa_rd
of care", the ethical issues they pose, particularly from the d~s
ability rights standpoint, are far from resolved and cannot be ~IS
missed. Rather, we need to listen to the concerns raised in ethical
debate and be responsive to them so as to make PND and PGD as
sensitive to all parties and ethically sound as possible. Now more
then ever it is essential that we not become complacent about how
we treat disabled members of our community. How we treat them
is indeed a measure of the quality of our society and how we are
willing to treat ourselves.
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Diagnostic Review

Ultrasound's Role in Obstetrics and Gynecology: Fetal Assessment
and Pelvic Bleeding

Nooreen Popat, Meds 2008, Janet Malowany, Meds 2008, and Jeremy Kelle1; Meds 2007

Ultrasound imaging is a useful and practical screening and diagnostic tool in many areas of medicine. The
diverse field of obstetrics and gynecology makes use of this tool in many clinical scenarios. Two will be discussed in the following article. The use of ultrasound in pregnancy provides substantial information concerning fetal life and development. It is used at various stages of gestation to provide information about fetal
growth and health. It also functions as a screening tool for congenital anomalies in fetal development. Another
role of ultrasound is in the assessment of pelvic bleeding. It is used as an initial screening tool to provide information about endometrial wall thickness, presence of polyps and other anatomical abnormalities. It assists in
clinical decision making with respect to planning further diagnostic tests and future follow-up. Ultrasound is
a highly utilized and very effective method of assessment in the field of obstetrics and gynecology.

Ultrasound is a useful and important diagnostic tool in many
fields of medicine. It has a great clinical utility and its impact on
the practice of obstetrics and gynecology has been tremendous. It
is a non-invasive and non-radioactive method of assessing and
examining anatomy, pathology, progression of disease and fetal
development. Since ultrasound is a non-radioactive imaging
modality, it is of particular utility in the practice of obstetrics and
gynecology. Radiation exposure in pregnancy must be avoided, so
other imaging techniques such as X-ray and CT cannot be used.
This aricle provides a brief overview of two of the common uses
of ultrasound: prenatal assessment of fetal development and
pelvic bleeding.
An assessment of fetal life and pregnancy is crucial to good
outcomes for both the mother and the baby. Ultrasound allows for
regular and safe assessment of many important factors that contribute to a healthy pregnancy and delivery. These include congenital anomalies, assessment of multiple gestations and assessing gestational age as well as overall health of the fetus .
In contrast, the evaluation of pelvic bleeding must be initiated quickly and assessed adequately. Ultrasound is a useful screening tool to differentiate between benign and malignant causes as
well as guiding further diagnostic tests.
Ultrasound has an immense role in assessment and diagnosis
in the field of obstetrics and gynecology and the following discussion offers only a segment of its broad applications.

PRENATAL ULTRASOUND
Although routine ultrasound is recommended for all pregnant
women in their second trimester 1, its judicious use remains controversial2,3. Many early trials provided conflicting results about
its usefulness for pregnant women4·6, raising questions about its
optimal timing as a screening or diagnostic tool. The value of
ultrasound has revolutionized obstetrical care due to its ability to
visualize the developing fetus throughout the pregnancy.
The components of a basic ultrasound examination differ
according to the trimester of the pregnancy. In the first trimester,
the main goals are to confirm the presence of an intrauterine
pregnancy and the location of the gestational sac; to identify fetal
viability through cardiac function ; to determine the presence of a
multiple gestation and its chorionicity/arnnionicity; to assess gestational age through crown-rump length; and to evaluate maternal
pelvic organs for abnormalities including the uterus, adnexal
structures and cul-de-sac7. For ultrasonic examinations in the second and third trimesters, one is able to survey fetal anatomy more
comprehensively. A basic ultrasound examination would include
determining the fetal number, fetal presentation, documentation
of fetal cardiac activity including heart rate, placental location,
amniotic fluid volume, assessment of gestational age and weight
through fetal biometry, fetal anatomical survey and an evaluation
of maternal pelvic organs including the cervix and lower uterine
segment?.
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Accurate gestation dating has been a major benefit for early
ultrasound investigations. Assessed during the first 8-12 weeks,
the crown-rump length is the most accurate method to date gestational age throughout pregnancy, correctly determining the
expected date of delivery within 5 days&. Between 14 and 26
weeks, the gestational age may be approximated by combining
the biparietal diameter, head circumference, abdominal circumference , and femur length, each of which has a variation between
7-10 days in the second trimester9, IO. Although more accurate in
the first trimester, there is no clinically significant difference of
gestational dating during the first two trimesters, but it is more
variable during the third trimesterll . With more accurate gestational dating, there is a reduction in misdiagnoses of intrauterine
growth restrictioni 2, in the use oftocolysis for inhibiting preterm
labour 13, and in post-term labour inductionsi4, 15.
The earlier identification of multiple births has also contributed to better perinatal outcomes, and routine ultrasound is
better able to diagnose twin pregnancies5, 15.
The prenatal detection of congenital anomalies has been a controversial benefit of ultrasonic examinations. One can identify a
spectrum of anomalies detectable throughout different trimesters,
with central nervous system abnormalities being the easiest to
detect in earlier assessments. Genetic abnormalities such as aneuploidy can also be easily detected early in pregnancy. Coupled with
maternal serum screening, over 90% of trisomies 18 and 21 can be
detected in the first trimesteri 6. The Helsinki trial demonstrated a
significant increased detection offetal anomalies upon introduction
of routine ultrasounds, and the significant reduction of the perinatal mortality rate was attributed primarily to the increase in elective
terminations but also to the increased detection of multiple births5.
The Eurofetus study also demonstrated increased detection of fetal
anomalies through routine screening, primarily of central nervous
system, urinary tract or musculoskeletal origin4. The RADIUS trial
also discovered increased fetal anomalies upon routine screening
but it did not uncover any improvements for perinatal outcomes
such as mortality, preterm birth, birth weight and neonatal morbidity6. These discrepancies have been attributed to the strict inclusion
criteria for low-risk pregnancies and the lower rate of elective terminations3. Yet, evidenee also suggests that even without an
increase in abortions, increased detection of fetal anomalies result
in better neonatal outcomes 17.
Because 75-90% offetal anomalies occur in women considered
to be low-risk, advantages of routine ultrasound include accurate
gestational age, decreased labour inductions, early identification of
multiple gestations, the detection of anatomical fetal malformations
and fetal growth restriction and overall improved perinatal mortality ratesi 5, 19. This is the basis for the recommendation of routine
ultrasounds for Canadian women in their second trimester' , with the
optimal time between 16-20 weeks allowing for a more complete
anatomical assessment?. The Society of Obstetricians and
Gynaecologists of Canada does not recommend routine ultrasonic
screening prior to 14 weeks unless patients present with specific
clinical indications (Table 1)20. The American College of
Obstetricians and Gynecologists does not mandate any routine ultrasound screenings, particularly if the patient is at low risk with no
other indications for sonography, leaving the decision to both the
physician and the patient?.
8
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Table 1: Recommended guidelines for first trimester ultrasounds by the SOGC20
.
I. For assessment of threatened abortion to document fetal viability or for incomplete abortion to identify retained products
of conception.
.
2. For assessment of gestational age when last menstrual penod
date is uncertain. First trimester ultrasound is not recommended to diagnose pregnancy, to date pregnancy when last
normal menstrual period and physical examination are concordant, or to investigate an inevitable abortion.
3. Prior to pregnancy termination.
4 . During diagnostic or therapeutic procedures requiring visual
guidance (e.g., chorionic villus sampling, amniocentesis) and
prior to cervical cerclage placement.
5. For suspected multiple gestation to allow for reliable determination of chorionicity or arnnionicity.
6. For suspected ectopic pregnancy, molar pregnancy, and suspected pelvic masses.
7. For early assessment of anatomic development in situations
of increased risk for major fetal congenital malformations.
8. For nuchal translucency screening when offered as part of a
comprehensive prenatal screening and counselling program
by experienced operators with appropriate quality assurance
processes in place.
ULTRASOUND FOR PELVIC BLEEDING
Ultrasound is not just a useful tool to screen for pelvic, uterine and fetal abnormalities; it is also helpful in discriminating
between differential diagnoses for pelvic bleeding. Clinically,
pelvic bleeding is a more common problem in postmenopausal
women than during any other stage of female reproduction2I.
Postmenopausal pelvic bleeding can be due to one of two broad
categories of causes: benign and malignant. Pelvic bleeding is due
to endometrial carcinoma in 10-20% of cases and to benign causes like endometrial atrophy, polyps, and hyperplasia in the
remaining 80-90% of ca es22.
In cases of pelvic bleeding, transvaginal ultrasound is frequently used as the initial exploratory tool to reliably examine
both the thickness and the echostructure of the endometrium. This
initial exp loratio~ wi~l help determine if further investigation,
such. as endome~~l bwpsy or dilatation and curettage (D&C), is
reqUired . In addition to simple transvaginal ultrasound, saline
infusion sonohysterography (SIS) can also be used. SIS involves
the use of transvaginal ultrasound while the uterus is ex and d
via insertion of small quantity of saline through a cathefer. S~S
enhances endometrial imaging by using saline as a contrast
d._
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testing is done 2s. Studies have shown that this is a reliable cut-off
value with a false-negative rate as low as endometrial biopsy or
D&C2 1• An endometrial thickness of greater than 4 mm is associated with causes such as polyps, benign hyperplasia, and carcinoma, with the probability of carcinoma increasing with greater
thickness. If the endometrium is thicker than 4 mm or if it can'
not be observed accurately, then SIS is used as the next exploratory tool, possibly followed by endometrial biopsy or D&C. If polypoid lesions or focal thickenings are observed, then histological
assessment of these tissues by endometrial biopsy is the next step.
The combined use of transvaginal ultrasound with the 4 mm cutoff as the first step to assess pelvic bleeding is fiscally responsible for two reasons: firstly, it decreases the total number of
endometrial biopsies performed; secondly, it is less costly than
performing an endometrial biopsy as the first step26.
Concurrent examination of the echo structure of the thickened endometrium or uterine mass may help to distinguish benign
from malignant hyperplasia. More specifically, homogeneous
thickening suggests benign hyperplasia, whereas heterogeneous
thickening may be indicative of malignancy. Since there is no
clear distinction between these two categories of thickening,
cases where endometrial thickening or intraluminal masses are
observed require further histological investigation, by either
endometrial biopsy or D&C, in order for a definitive diagnosis to
be made27.
Simple transvaginal ultrasound and SIS are two useful tools
in the assessment of postmenopausal pelvic bleeding. These tools
can help to diagnose certain benign causes of pelvic bleeding,
such as post menopausal endometrial atrophy. In addition, they
can provide clear indications for more invasive assessment, such
as endometrial biopsy or D&C, in cases where focal or diffuse
thickenings, or polypoid lesions, are observed. Lastly, they can be
performed at relatively low cost, compared to endometrial biopsy
and D&C, making their use as initial exploratory tools economically conscientious.

CONCLUSION
Ultrasound is a commonly used tool in the clinical practice of
obstetrics and gynecology. It is a quick, inexpensive, non-radioactive imaging method of assessing anatomy, pathology and fetal
growth. Its application in pregnancy and fetal assessment as well
as pelvic bleeding illustrates its diverse function and applicability in the clinical setting. Ultrasound continues to be an effective
imaging technique in many fields of medicine and as the technology progresses indications for its use will continue to grow.
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Profiles

A Conversation with Dr. Paul Bernstein, Obstetrician/Gynecologist

Betty Lee, B.Sc., Medicine 2006

Practicing as an obstetrician/gynecologist for over 25 years, Dr. Bernstein is an exceUent role model for aspiring physicians. Upon graduating from the University of Toronto's undergraduate medical prog_ram, D~.
Bernstein first decided on a career in family medicine. However, after working for 2 years as a family physician, he discovered that his true passion was obstetrics and chose to pursue an Obstetrics and Gynecology residency at the University ofToronto. In addition to being an accomplished clinician, Dr. Bernstein is also a weUrespected teacher.
Dr. Bernstein currently practices at Mount Sinai Hospital, one of the premier teaching facilities in Toronto.
For seven years he also served as Residency Program Director for the University of Toronto Obstetrics and
Gynecology program. Dr. Bernstein continues to further the education of both medical students and residents
in his role as an Associate Professor at the University of Toronto's Faculty of Medicine.

Why did you choose to specialize in obstetrics and gynecology?
I think it was the fascination with it all. For me, I liked the
who le idea of obstetrics and looking after women who were having babies. I had actually done family medicine for two years
first , and in those days it was a little easier to switch fields ,
because we had the option of starting off in family medicine and
then applying and specializing in a specific field later on. I had
always thought about practicing in obstetrics. When I was a family doctor, I enjoyed everything, but obstetrics was the favourite
part of my practice so I could tell that I wanted to specialize in it.
I could tell that it was a career that I cou ld do for a long time
because there are so many interesting facets involved and I liked
the lifestyle. I enjoy being bu y and having to juggle many task .
Though these days, there are subspecialties in obstetrics and
gynecology where you can have more structure and definitely the
lifestyle is much more structured now than it used to be.
Are you finding that the variety of subspecialties in
obstetrics/gynecology is expanding?
Yes, I think so. Currently there is a significant market for the
subspecialties in obstetrics and gynecology. There is definitely
the opportunity to become an 'expert's expert' with the volume of
new information both in clinical practice and theoretical science.

10
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When does one choose to sub-specialize and what is the
process for doing so?
At thi point there is no streaming in the obstetrics/gynecology re idency program. However this is an issue that is discussed
on a regular basis because of the thought that streaming could
eliminate some of the residency that may not be utilized afterward in practice. For example, if you decide that you would like
to focus on gynecological pelvic surgery and not on obstetrics,
one could potentially decide to structure their residency to suit
that and focus more of their training time on surgery and less in
obstetrics. Streaming i an idea that is being thought about, but at
this point, what happen is, in our program at Toronto, there is
elective time. So for instance, if someone would like to be a surgical oncologist in obs/gyn, there is a chance for that person to do
an elective with someone in the field and get a better idea of that
ubspecialty. There are some individuals who come into the residency knowing exactly what they want do o we try to help them
expedite that, and expose them to the specific field that they are
interested in. Doing research and having experience in the subspecialty of your choice is beneficial when applying for fe llowships.
As the former U ofT Residency Program Director what
attributes did you look for in potential residents?
'
Well, when I was the Residency Director, I always felt that it

was very important to interview people and give everybody a fair
chance to show their stuff. We rarely turned anybody away for an
interview because we thought that that was unfair. We try to be
fair. We evaluate everybody 's file , their letters of reference, their
interview and people's general impressions. Then we give them a
score and rank the people that we really want. The interview is
important and most of the students interview extremely well ,
because the students are bright and know how to interview. The
interview is structured, we try to make it fair, and score it in an
objective manner. In that way, even if different people are leading
the interviews, the students will get similar interviews. We want
somebody who we think is well rounded and we want people who
have shown an interest, at some point, in the specialty. Basically,
those are the criteria that we look for.

Is it important to do an elective at the facility that you
want to have your residency in?
Well I don 't think that it is the deciding factor, but I guess it
helps if people have seen you work. You can't beat working in the
field with somebody and seeing how they apply themselves. We
think that it is very important, in the way the residency is set up,
for people to be good team players. During residency, you really
depend on each other. It certainly doesn 't hurt to do an elective
there, and it might even help. Of course, it is impossible to do an
elective everywhere, and with our program, we have had people
from across the country. So I don 't think it really matters.
How do you determine what percentage of your practice
is obstetrics versus gynecology?
Well you can choose how you structure your practice. For
instance, I know some clinicians that don 't practice any obstetrics; their focus is mainly on gynecology. There are others who do
prenatal care and not deliveries. Some doctors have a higher
weight in their obstetrical portion and do not perform much operative gynecology but rather general gynecology. Oftentimes,
obstetrical patients whom you treat prefer to have you follow
them as their gynecologist. You can definitely profile your practice however you choose to suit your interests.

Can you describe what your typical work week is like?
In my typical week, I have about 5 or 6 half days in my office
and I work one night on call. I spend one half day covering the
labour floor. The rest of the week, I have time to do some surgery
' like C-sections, and catch up on my paperwork. I like to start my
days early. I make my rounds at 7:00 or 7:30a.m. and then I go
into the office. I structure my lifestyle so that I don't have to work
late. My day is usually done by 3:30- 4:00p.m.
I also like working in a teaching facility. The benefits are that
you have a lot of support. Many of my colleagues are sub-specialists so they are available for consulting, and residents are
always helpful in managing your patients.

do deliveries a certain night. The system works. Even if you
choose to work nights, you can structure your nights and determine your own schedule.
In terms of the practice of obs/gyn, we have more technology. Now there is fetal monitoring and screening tests have
changed. Gynecological surgeries are more minimally invasive.

How do you see the field of obstetrics and gynecology
evolving in the future?
I personally think that it will evolve into more sub-specialization, perhaps into surgica l and non-surgical aspects. I think
that with the issue of streaming, it behooves us to investigate it in
more detail. As the body of knowledge increases, the residents
will be responsible for learning far more techniques and information than in the past. It would be practical to have streaming, as
that would provide focus and improve resources for new clinicians.
What's the favourite part of your career?
I enjoy interacting with the patients. I don 't think that I could
have ever done anything that did not involve any patient care. I
like following my patients and seeing how they progress from day
to day. I have patients that I've followed for a long time. I see
them before they have their kids, I take care of them when they
have their kids, and I see their kids grow up . It's good!
The interesting thing is that when I get up in the morning, I
don 't know what's going to happen to me that day! It 's so exciting, it's a great mix and you get to do something that makes a big
difference!

Talking about
pregnancy, before
it happens ...
It's your job.

How has the specialty changed throughout your career?
The lifestyle is definitely not like it was in the old days . I
think that these days, you can have your schedule be whatever you
want it to be. There's group coverage and in our institute, we have
a call system so people are free if they do not want to come in and
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Clinical Procedures

The Pap Smear

Christopher Gillis, Meds 2008

The Pap smear is a screening test for cervical dysplasia,
which is an early finding of possible cervical cancer. The Pap
smear procedure is named for Dr. George Papanicolaou ( 1883 1962) a physician from Greece. Dr. Papanicolaou first published
his paper in 1943, along with gynecologist Dr. Herbert F. Traut,
showing that cellular abnormalities could be detected by vaginal
smear before a possible malignancy became invasive. The "Pap
smear" quickly became a routine screening technique and physicians were encouraged to include it during routine visits for contraceptive visits.'
Human Papillomavirus (HPV) is recognized as the etiological agent for the development of cervical dysplasia , especially
subtypes 16 and 18.2 After puberty and before the age of 30, exually active women have a higher chance of acquiring new HPV
infection.' If not eliminated by the immune system, the virus can
cause dysplasia of the cervical transformation zone. In thi region
of the cervix, columnar ce ll are actively participating in quamous cell metaplasia. It is persistent HPV infection that can cause
progression to high grade dysplasia and cancer.' ,2 After age 30,
detected HPV infection is most likely to be the result of a persi tent infection and is therefore more likely to progress.'
The pap smear i coll ected using a wooden patula and a
cytobrush. The collected speci men is then applied and fixed to a
glass slide.3 The new tandard for Pap mears involves the u e of
liquid-based specimen storage. The smear is performed by ampiing the exocervix and the endocervical cana l at the tran formation zone. The spatula and cytobrush are used in combination to
sample the entire area of the transformation zone. The sample is
then smeared onto a slide and then immediately fixed with a cytological fixative in preparation for examination by a pathologist.
The focus of the technique is both to eliminate samp ling error by
ensuring the entire transformation zone is sampled and to eliminate a drying artifact on the slides. The liquid based procedures
are considered to be more effective by reducing the incidence of
inadequate smears. The cells are collected in the same way as the
conventional Pap smear, but the sampling device is placed in liquid medium for the purpose of transport to the laboratory. This
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newer liquid technique allows the cells to be plated more evenly
upon the slide for review. Its other benefits include a reduction in
cellular distorti on, decreased debris on the slide and decreased
contamination by red blood cells on the slide. One of the liquid
based procedures is called the the ThinPrep Pap smear. Results of
a study based on a comparison of the ThinPrep Pap smear and the
conventional Pap smear shows an increased detection of low level
cervical dysplasia (L-SIL) of 9.4% as compared to only 8% with
the conventional Pap mear.4.5
The current recommendation is that women should have their
fir t Pap te t about 3 year after the onset of intercourse, or by the
age of 21. 1 The Pap smear screening should continue every year
for exually acti e women until there have been 3 negative Pap
mear results, then the te ting can be performed only every 2 or 3
year at the discretion of the physician.' ,4 The recommendations
for treatment and follow-up following abnormal Pap smear
results are ba ed on the Bethesda system outlined at the 2001
American Society for Colposcopy and Cervical Pathology
on ensus Conference.6
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Medicine and the Internet

Telemedicine in Ontario

Deric Morrison, Meds 2005

Although Canada has one of the finest health care systems in the world, with state of the art medical equipment, training, and care, being the second largest country in the world it is often difficult to have these services delivered to aU the inhabitants of our nation. It is especially difficult for residents of rural areas to obtain
access to the medical care that is characteristically delivered in larger urban centers. A recent strategy for
delivering the advantages of large center, high technology health care to rural areas is the use of telemedicine.
Specifically, the NORTH Network and the telestroke Ontario programs have recently been implemented to
provide previously unavailable services to rural areas. This article examines the possible advantages telemedicine may provide rural communities, and explains how the NORTH Network and telestroke Ontario may be
used to improve rural health care.

The health care provided in Canada is among the best in the
world. We are fortunate in this country to have access to exciting
new medical technology, excellent medical training centers and
~ medical personnel who are held to the highest of standards.
However, being the second largest country in the world provides
, challenges, in that much of Canada's land is composed of rural
area. While it is true that the majority of Canadians live in, or very
near, urban centers that offer a full complement of medical services, a significant proportion (-31 %) live in rural and remote
locations that render it difficult to obtain timely medical care.
This problem is compounded by the lack of specialized care in
rural centers that may have access to hospitals and physicians but
do not always have the resources or personnel to perform necessary specialized medical treatment. In recognition of these challenges to our health care system, advances have been made in the
field of telemedicine to ensure that all residents of Canada have
timely access to the care that they require. Telemedicine has been
defined as the use of information and communications technology to provide health care services to individuals who are some
distance from the health care provider. 1 Telemedicine can include
teleradiology, telepsychiatry, telesurgery, transmission of
echocardiographic or obstetrical ultrasound images, the telehealth
Ontario program, or electronic referrals and consultations. These
programs are ideal for a country such as Canada that has access
to excellent health care but faces geographical limitations in

r

delivering this care to all of its residents.
One of the most ambitious telemedicine endeavours in this
country has been the use of the NORTH Network telemedicine
program in Ontario. This program began as a feasibility study in
1995 of how telemedicine might be able to improve health care in
northern Ontario. The NORTH Network began in earnest in 1998
and since then has expanded to a 64-site network. The NORTH
Network allows members of rural northern Ontario communities
to experience consultations with medical specialists via telemedicine. There are more than thirty medical specialties available to
users of the NORTH Network, including medical and surgical
specialties and sub-specialties, anaesthesia, radiology, psychiatry,
obstetrics, dermatology, paediatrics, physiotherapy and speech
therapy. The technology that makes telemedicine consultations
through the NORTH Network possible is available at 59 sites in
rural northern Ontario; these sites can then be linked to centres
offering specialized care such as Winnipeg, Thunder Bay,
Sudbury, North Bay, Timmins and Sault Ste. Marie. Also, when
necessary, consultations can be made through the NORTH
Network to academic hospitals in southern Ontario. The technology used by the NORTH Network is simply operated and consists
of video screens with input from remote cameras and microphones, which can be operated by a touch pad. Several medical
devices can also be attached to the unit when needed; for example, an otoscope may be connected to examine a patient's ear
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remotely. Also, radiology films and other images may be scanned
and transmitted through the unit. Over the past few years, the
NORTH Network has provided residents of rural northern
Ontario a valuable option in receiving medical care. Instead of
being required to travel long distances to see specialists - a situation that results in high cost to the individual as well as the hea lth
care system, delays before adequate treatment can be arranged,
and possibly even a complete lack of access to some services - it
is now possible for these individuals to see specialists located
hundreds of kilometres away from the proximity of their home
comrnunity.2 More research needs to be performed to determine
the benefit of these telemedicine services, but it seems reasonable
that an efficiently run rural telemedicine program should provide
many advantages to health care in much of rural Canada.
Another example of how telemedicine can be used to
improve patient care is the recently developed telestroke program
in Ontario. In recent years, the treatment of acute thromboembolic stroke has improved dramatically with the use of thrombolytic
therapy such a t-PA.3 However, there are concerns regarding this
treatment, namely that not all patients who have experienced a
cerebrovascular event qualify for thrombolytic therapy. Only
those who have suffered from a thromboembolic stroke would
benefit, whereas those who have had an intracranial haemorrhage
would likely have their condition worsened by thrombolytic therapy. Also, patients who have not experienced intracranial haemorrhage but are at higher risk of bleeding intracranially, such as
those with recent major surgery, bleeding diathesis, and significant comorbidity must be excluded from thrombolytic therapy.3.4.5 Another major obstacle in providing patients who have had
acute thromboembolic stroke with thrombolytic treatment is the
short amount of time in which treatment may be administered.
This make administering thrombolytic treatment to acute stroke
patients in small centres almost impossible without access to a
neurologist to confirm the appropriatene s of thrombolytic therapy. To this end, the telestroke program has been implemented in
Ontario.
The telestroke program is an initiative that give emergency
room physicians in North Bay and Sudbury hospitals 24-hour,
seven- day-a-week access to link with troke neurologi t at
Toronto 's Sunnybrook and Women 's ollege Health Science
Centre and the University Health Network. The program allow
the neurologi st to evaluate the CT image, the neurological asse ment and the history provided by the referring physician and to
determine the appropriateness of thrombolytic therapy. Telestroke
gives a significant population of patients in rural northea tern
Ontario access to specialized services and proven effective therapy for acute thromboembolic stroke that would otherwise be completely unattainable. It is to be hoped that in the future thi s ervice
can be expanded to provide access to the best medical treatments
for thromboembolic stroke to all residents of rural Ontario.6
Emerging technologies in telemedicine are an important
aspect of the future of the hea lth care system in Canada. Novel
approaches to the challenges of the large geography and dispersed
population of our country are necessary to ensure that all members of thi s nation receive access to the best health care available.
It is to be hoped that telemedicine programs such as the NORTH
Network and Telestroke can aid in making this goal a reality.
14
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Thinking on Your Feet

An Approach to Postpartum Hemorrhage

Jay Banerjee, Meds 2005 and Sujiva Heyn, Meds 2006

Case: Ms. Jones is a 30 year-old female journalist, G 3 T 2P 0 A0 L 2 who presents to the emergency department
in her 40th week of pregnancy in active labour. In her previous pregnancy, she sustained significant blood loss
secondary to uterine atony and is worried about recurrence of this problem. Her current pregnancy has been
uncomplicated, and she has experienced no blood loss, except for some minor spotting in her first trimester.
She asks for your advice (as a clinical clerk) as to what will be done if she begins to hemorrhage?

As a clinical clerk, the experience of witnessing an obstetrical hemorrhage can be a nerve-wracking one. Postpartum hemorrhage is among the top five causes of maternal death worldwide
and a major cause of maternal morbidity.' In the developing
world, the maternal death risk is one in l 000 deliveries;2 in the
developed world maternal morbidity is usually a result of significant blood loss.
Postpartum hemorrhage (PPH) is classically defined as blood
loss exceeding 500mL before completion of the third stage of
labour.3 Signs and symptoms of hypovolemia may include fainting, lethargy, tachycardia, hypotension, pallor, and diaphoresis.
However, since a healthy pregnant woman can tolerate up to
1OOOmL of acute blood loss without significant hemodynamic
disturbances, clinical determination of blood loss is often underestimated.4 It has been suggested that a more clinically relevant
definition would be a drop in hematocrit of 10% or a hemorrhage
requiring immediate transfusion. s However, acute hemorrhage is
not reflected in hemotocrit for at least 4 hours, and full equilibration may take 24 to 48 hours. 6 Complications from such an event
include hypovolemic shock, renal failure, hepatic failure, adult
respiratory distress syndrome, and disseminated intravascular
coagulopathy. 7 In patients with a history of PPH, the recurrence
risk is between 20-25%.8
As a clinical clerk, one is often asked to take a complete history upon admission. A thorough obstetrical assessment should
include inquiry into the various risk factors for hemorrhage.

These include nulliparity, obesity, large size (for gestational age),
history of prolonged third stage, antepartum hemorrhage, previous postpartum hemorrhage, and operative deliveries. The major
causes of PPH include uterine atony, retained placental fragments, placental adhesions, lower genital tract lacerations, uterine
rupture, uterine inversion, and coagulopathies.9 If one is doing an
obstetrical rotation in a developing country, it is important to be
aware of the contributory factors to PPH. These include low
socioeconomic status, anemia, infrequent prenatal checkups, and
limited access to hospital staff and emergency resuscitative
resources.IO,ll However, it appears that multi-parity does not
increase the likelihood of hemorrhage.I 2
MANAGEMENT
As a clerk, the first step in the management of PPH is immediate resuscitation, identification of the likely source, and arrest
of bleeding. Resuscitative efforts with the aid of senior staff
should be initiated, including monitoring vitals (heart rate, respiratory rate, blood pressure, oxygen saturation), establishing two
intravenous access sites, volume replacement (Ringer's lactate,
Hartman's solution, or 0.9% saline), elevating the legs, cross
matching 6 units of blood, full blood count, clotting screen, baseline urea and electrolytes, and monitoring urine output. Evidence
of hypovolemia is monitored with vitals and treated with crystalloid and blood products as required. Supplemental oxygen should
also be given to increase oxygen delivery to microvasculature.
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Bleeding that begins before placental delivery is often due to
a laceration or coagulopathy, whereas bleeding that occurs after
placental delivery suggests uterine atony, inversion, or retained
placental fragments.13
During the clinical clerkship year, one plays a large role after
the baby is delivered - a role not to be underestimated . Active
management of the third stage of labour is recommended for
high-risk cases and is associated with reduced blood loss and a
reduction in PPH of more than 40%.14 The principals governing
active management include early cord clamping, prophy lactic
uterotonic drugs before placenta l deli very, and ensuring complete
extraction of the placenta. If a patient begins to bleed despite
these steps, more invasive techniques are utilized .
Active management includes bimanual compression, examination and evacuation of the placenta for retained products, and
repair of any tears . Studies indicate that prostaglandins, which are
endogenous uterotonic agents that he lp myometrial contractility,
are released as a result of intrauterine pressure, myometrial
stretching, or manipulation.15 In addi ti o n, exogenous uterotonics,
such as oxytocin, ergometrine, and IS-methyl prostaglandin
F.2(PG-F.2) can be utili zed. However, there is an adva ntage of
using PG-F.2 due to its rapid onset of action and ease of admini stration . Ergometrine (0.25 -0.Smg IM) and oxytocin require protection from light, refrigeration, and sterile administration . 16 In
addition, ergometrine cannot be g iven to hypertensive women . A
recent World Health Organization study suggests the use of oxytocin ( 10 IU IV/IM) as a first-line agent; however, rnisoprostol
(600ug oral ) has also been shown to be as effective as oxytocin
alone and a more practical option, particularly in rural settings.17, 18
For those failing active management, uterine packing with
gauze remains the standard of care. The Sengstaken-Blakemore
catheter has recently emerged as a diagnostic and therapeutic tool
via the "tamponade test". The catheter is inserted into the uterine
cavity and inflated with normal saline to create a tamponade to
identify women who w ill respond to thi s intervention; those w ho
do not are prepared for laparotomy.19 Other options available
include a Foley catheter to achieve the tamponade effect; however, its limitations include reduced leve l of inflation . In developing
countries, with limited resources, a hydrostati c condom catheter
is often used to control PPH qui ckly and effectively.20
In the past, as a last resort, the surgica l standard of care for
patients was a hyste rectomy and ligation of internal iliac arteries.21 Today, less invasive procedures are used . These include the
B-Lynch stitch and multipl e square sutures.22 With the advent of
improved radiologi ca l techniques, selective a rteria l embolization
will be an option that offers minimal complication rates and
preservation of fertility.23
In summary, when on the ward it is important to identify the
risk factors for PPH when obtaining the history, and to be able to
recognize the early signs of shock. Appropriate knowledge of medical and surgical treatment modalities and the ability to counsel
patients effectively is important in managing obstetric patients. In
the case presented, given the patient 's history, there is a high recurrence risk of hemorrhage. As a c lerk, a complete history and close
monitoring of the patient's progression through the labour and
delivery stages are warranted, as well as active medical management of the third stage with a uterotonic agent. If possible, delivery
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· te medical
.
in a tertiary care centre is suggested where the appropna
resources and support services will be available to m anage tlus case
effectively. A well-thought out approach to obstetric hemorrhage
will enable one to deal with patients in a calm and rational manner.
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Joint Replacement: Past, Present, and Future

Sujiva Heyn, Meds 2006 and Jay Banerjee, Meds 2005

Case: Mrs. Joint is a 55 year-old with gradual onset of a chronic, continuous, progressive non-inflammatory polyarthritis, asymmetrically involving the joints of the hands, left knee, and hip, associated with a strong
family history of osteoarthritis. She is stiff every morning for about 20 minutes, but generally worsens through
the day and with activity. She is sometimes stiff for 1 or 2 steps after prolonged sitting. She complains of some
pain, swelling and some loss of range of motion. On clinical exam her joints are warm, but non-erythematous.
She is otherwise healthy, but is worried about needing hip replacement in the near future.

Joint replacement is one of the most commonly performed
procedures in the developed world. Total hip or knee replacement
is usually related to osteoarthritis or some type of arthritic condition. Dr. Bourne, an orthopedic surgeon at the London Health
Sciences Centre, reports that in Canada there are 43 ,000 hip and
knee replacements yearly, with a 47% increase in replacements
over the last five years. This figure is expected to double by
2020.1 Hence, the clinical importance of hip replacement lies in
the significant medical and social implications associated with
the procedure.
While joint replacement, such as hip arthroplasty, is an effective intervention strategy, the ballooning cost places a huge strain
on the medical system. Population projections for 2041 indicate
25% of the population will be over the age of 65 years of age, and
it is anticipated that the demands will surpass the supply of
resources for joint replacement.2 Hence, there is a pressing need
to address the significant medical and social implications associated with this procedure which will continue to be a growing
health concern among Canadians.

PAST AND PRESENT
The first breakthrough in this field was contributed by Sir
John Charnley, who developed the low friction arthoplasty in the
early 1960s.3 He experimented with stainless steel on Teflon, and
later with high density polyethylene. Over the years, bearing surfaces have improved significantly. Currently, a high molecular

weight medical grade polyethylene is used. More recently it has
been discovered that if you can irradiate the polyethylene in an
oxygen free environment you can get cross linking and it will
reduce the wear by about 90%. Cross-linked polyethylene has
resulted in increased tensile strength and longevity of parts, thereby reducing the need for revision total hip arthroplasty.4

CANADIAN SITUATION
In Canada, the incident requirement rate of 2.23 total hip
replacments per 1000 people. In 1996, the number of surgeries
provided fell short by the 43%, while the cumulative backlog of
people requiring surgery was about 80 000.5 At London Health
Sciences Centre, the average waiting time from initial family
physician consult to surgery is approximately 24 months.6 The
significant gap between health services required and provision of
these services demonstrates a significant inadequacy in the delivery of health care in Canada.
The creation of the Ontario Joint Replacement Registry provides a means to improve the delivery of joint replacements in the
province.? In this era of evidence-based medicine, the registry
will provide a tool to monitor replacements parts, assess the effectiveness of surgical procedures, and to understand patient demographics and profiles . The Western Ontario and McMaster
University Osteoarthritis index (WOMAC) is used to assess the
severity of disease for surgical candidates. s The registry has been
in effect since 1995, and the data obtained will be an invaluable
UWOMJ 74(1 ) 2005 17

mechanism for health policy advocates and physicians to improve
the quality of joint replacement surgery and to address the
increasing population demands for their care.

COST
At the London Health Sciences Centre, the total cost of a hip
replacement is approximately $10,000. The distribution is as follows: prosthesis cost at $2200, five day hospital costs at $5000,
rehabilitation therapy at $1000, physician fees at $600, anesthesia
fees at $400, orthopedic consult at $120, and miscellaneous drug
expenses.9 In Ontario, the entire cost is covered by OHIP. A common index to assess the outcome of a health care procedure or
service is the cost utility measured in terms of quality-adjusted
life year.I O, II , 12 According to Dr. Bourne, total hip and total knee
replacements cost $5000 per quality-adjusted life year.
Comparatively, treatment of hypertension cost $15,000 per quality-adjusted life year and a coronary-artery bypass graft cost
$55,000 per quality-adjusted life year. Any intervention below
$20,000 is considered cost effective, therefore hip and knee
replacements are considered cost effective.1 3 The procedure is
considered cost saving due to the enormous care-giver costs
incurred by those who do not receive the intervention. In essence,
total hip replacement virtually takes a person who is very disabled
and restores them to normal quality of life.14

COMPLICATIONS AND READMISSION
The most common complications for joint replacement
include: pulmonary embolism, deep vein thrombosis, compartment syndrome, stroke, myocardial infarction, avascular necrosis,
dislocation and infection.1 5 Due to constrained health care
resources the lengths of post-operation stay have decreased by
50%, while readmissions due to complications after surgery have
increased by about 32%. 16 With a hospital stay ofthree days there
is a 10% chance of readmission ; however, while a five or six day
recovery period drops the rate to 2-3%. 17 Each readmission co ts
the health care system about $1000 per day. IS While joint arthroplasty can be performed safely with excell ent pain relief and ignificantly improved functional outcome, the incidence of complications and readmission poses a health management concern .
RECOVERY AND RANGE OF MOTION
The recovery period ranges from 12 to 15 weeks, depending
on the occupation of the patient.1 9 The range of motion of artificial hips is full , whereas for knees there is some decrease in range
of motion. The increased functional capability brings about the
greatest improvements in the patients' quality of life, along with
improved sleep patterns and increased social interactions. The
psychological profile of the patient is also markedly improved
after surgical intervention.20 However, functional requirements of
patients vary depending on cultural background, due to differences in activities of daily living.2 1 Hence, the success of joint
replacement therapy for a patient is relative and largely determined by the individual 's expected level of function in a society.

THE FUTURE
The delivery of hip replacements is an area that requires significant study and innovation. A recent international compari son
of total hip arthroplasty cost and practice patterns indicates that

18
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80% of surgeons were under pressure to reduce cost of the p_roce~
dure, and 68% under pressure to reduce the length of ~at~ents
hospital stay. In this survey 30% indicated that negouatmg a
.
.
'
.
h
t important
reduced tmplant pnce from the supplter was t e mos
cost-cutting measure as the variability of cost can be as much ~s
'
·
·
rth paedtc
700% for an implant.22 In other words, mfluencmg o 0
. pattern should be a fiocus a rea of health care
surgeon's practice
policy-makers.
Another possible strategy is to regionalize hip arthrop 1asty to
an outpatient procedure. The apparent advantages of such a strategy are shorter lengths of stay, ability to perform -~crea_sed number of procedures, decreased costs and shorter wa1tmg-t1me~. ~he
possible drawbacks of such a strategy are increased rea?misswn
rates due to complications and increased use of cor:nm~Jmty-based
services. Studies in Alberta indicate that regwnahzatwn has had
minimal impact on death and readmission rates, making this a
plausible strategy.23
Also, primary care education to recognize congenital hip
dysplasia is an equally important prevention strategy. At the
London Health Sciences Centre, approximately 75% of hip
replacements are related to dysplastic hip conditions. 24 The contribution of a family physician in recognizing and appropriately
treating these conditions in infants would thereby alleviate the
demands on the health care system through a cost-effective and
efficient early intervention strategy.
The future of hip replacement surgery is indeed a promising
one. In addition to the technological advances discussed previously, with the advent of minimally invasive or SMART instruments the urgical precision of the procedure is markedly improving which will lead to fewer complications and shorter recovery
times once uch in truments become commonplace in the surgical field .25 In addition, on-going laboratory studies on the regeneration of cartilage surfaces may one day result in eliminating the
need for the procedure entirely. 26
While the medical advances will alleviate some of the
demand for the joint replacement the resource management
issue hall determine the quality and quantity of care available to
patient . Hence it is necessary for future physicians to be aware
of the multi-factorial aspects of health care in order to effectively
erve the growing demands of the Canadian population.
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Zebra Files

Amniotic Fluid Embolism- An Unpredictable and Often Catastrophic
Obstetrical Emergency

Stephen Chihrin, Meds 2008 and Leslie Wong, Meds 2007

Amniotic fluid embolism (AFE) is a rare and unpredictable obstetrical emergency, occurring in less than 1 in
20,000 births. It is of considerable importance given that mortality rates exceed 60% for mothers and 20%
for newborns. Symptoms begin with acute dyspnea and shock and frequently progress to cardiac arrest within minutes. Significant uterine hemorrhage, neurological sequelae, and fetal bradycardia often follow in
patients who survive the initial cardiorespiratory events. Two models for the pathogenesis of AFE have been
proposed and are detailed in this report along with basic principles of diagnosis and management.

Amniotic fluid emboli m (AFE) is a rare and deadly labor
event in which amniotic fluid gains entry into maternal circu lation rapidly leading to severe respiratory, cardiovascular, and neurologic complications' . This condition was first documented in
19261 ; however, medical-historical accounts of the unexpected
death of Princess Charlotte of Wales in 1817, and the public outcry leading to her obstetrician's ultimate suicide, suggests that
AFE was observed much earlier2.
Amniotic fluid embolism has been estimated to occur in 1 in
20,000 pregnancies3. As of yet, no preventive strategies have been
developed for AFE, nor can it be predicted. Compounding this
chall enge, maternal and fetal mortality rates of over 60% and
20% respective ly are regularly reported4 . In patients who survive,
neurological seque lae have been reported as high as 85%4-6.
It shou ld also be noted that AFE has been observed during
ruptured membranes and caesarian section, though insufficient
data exists to estimate incidence or predisposing factors?.

PATHOPHYSIOLOGY
AFE occurs when amniotic fluid gains entry into maternal
circulation . The current belief is that whi le fluid exchange does
not necessarily lead to AFE, AFE is more likely to develop if the
delivery has led to a greater-than-normal pressure gradient
between the amniotic fluid and maternal circulations. Other
researchers have suggested that certain maternal factors and/or
factors in the anmiotic fluid may influence the onset of AFE'.
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While the pecific pathophysiological events have not been
c learly identified, the traditional pathway is as fo ll ows9:
Amniotic fluid enters maternal circulation and reaches pulmonary circulation through the pulmonary artery. Right-toleft shunting is evident, as emboli are frequently found in
coronary va culature a well.
Leukotrienes, surfactant, thromboxane A2 , endothelin,
vernix, fetal hair, and mucin act upon the vasculature of the
lungs, leading to negative inotropism, capillary leak, and ultimately bronchospa m.
Pulmonary congestion en ues, leading to right heart failure ,
decrea ed cardiac output, as well as hypotension.
Disseminated intravascular coagu lopathy may also occur
secondary to ~he effects of fetal thromboplastins, leading to
profus~ bl eedmg from the uterus and any iatrogenic entry
pomts mto maternal vasculature.
Systemic _ hypotension in the mother quickly leads to a
decrease m utenne and placental perfusion, which in tur
.
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Table 1: Proposed pathophysiological mechanisms of amniotic fluid embolism.
Embolism ModeJ9

Anaphylactoid Model tO

Etiology

- Direct emboli of amniotic/fetal origin

- Immune response to fetal particulate
matter

Pathophysiological Events

Amniotic fluid gains entry into maternal
circulation
- Fluid containing fetal tissue reaches
pulmonary circulation, results in capillary leak and bronchospasm
- Pulmonary congestion leads to a right
heart failure with drop in cardiac output,
hypotension
- fetal tissue gains access to arterial system through shunt or patent foramen ,
promotes coagulopathy

- Amniotic fluid gains entry into maternal circulation
- fetal tissues, in particular fetal epithelia
mucin-associated glycoproteins trigger
immune response as well as the release
of procoagulant factors
- va cular occlusion and vasospasms follow, trigger left heart failure and subsequent decline in cardiac output

Outcome

- Right heart failure, in addition to all
other characteristics noted

- Left heart failure , in addition to all
other characteristics noted

glycoproteins (which release procoagulant factors and
leukotrienes), which trigger vascular occlusion and vasospasm. A
key difference in this model is that it encourages left heart failure ,
an observation sometimes noted in AFE.
Table 1 compares the traditional and new AFE models. Some
experts have suggested that both models may operate simultaneously; however, more research into these theories must be conducted before conclusions can be drawn.

DIAGNOSIS
Diagnosis of AFE is difficult due to its rarity, acute onset,
and a lack of means for definitive diagnosis. Until recently, AFE
could only be diagnosed by examining fetal contents in the vasculature during autopsy 1.
Respiratory distress and cyanosis are the first signs of AFE
and are believed to develop within one minute of fluid transfer.
Hypotension and shock develop immediately after, as can symptoms of neurological origin such as confusion and seizures.
Within only a few minutes, reports have estimated that as high as
80% of patients progress to cardiac arrest, of which 50% do not
survives. Beyond this point survival rates generally increase with
the passage of time. Of those who survive, significant uterine
hemorrhage secondary to coagulopathy is observed with a frequency of approximately 40%1 3.
Clinical Suspicion
Generally, AFE develops during labour, though reports of
occurrence earlier in gestation and post-partum have been
madeto. Clinical suspicion for AFE centers around dyspnea and
hypoxia, cor pulmonale, disseminated intravascular coagulation,
CVS shock, hypotension, neurological compromise, and fetal
bradycardia?. Table 2 presents a summary of diagnostic criteria
currently in use by the United States Registry for AFE.

Table 2: Key criteria for the diagnosis of amniotic fluid
embolism'.
I.
2.

3.

4.

Acute hypotension with or without ensuing cardiac arrest
Acute dyspnea and cyanosis leading to hypoxia, with or
without respiratory arrest.
Coagulopathy- diagnosed either by severe hemorrhage without alternative explanation, or laboratory evidence of fibrinolysis.
Onset as early as onset of cervical dilatation, and as late as
30 minutes post-partum.

Transesophageal echocardiography has recently been investigated as a means to confirm clinical suspicion of AFE. Important
findings include enlarged right ventricle and aD-shaped left ventricle that contracts normally and appears to be operating under
reduced volume load. Significant dilation of the main and distal
pulmonary trunks is also often evident. To support the diagnosis
of AFE, other cardiac findings that may play a causative role in
heart failure must be ruled out, including regional wall defects,
valve rupture, congenital defects, and outflow obstructionto.
Finally, modest serum tryptase elevation (< 10 ng/mL) has
been observed, assisting the diagnosis of AFE and adding evidence to the immune-mediated mechanism for the development
of AFE symptoms'' · Serum tryptase is released exclusively from
mast cells and is significantly elevated in fatal anaphylaxis.

Post-mortem Diagnosis
Gross findings are relatively non-specific for AFE, and
include patchy edema, atelectasis, disseminated intravascular
coagulation, and pulmonary hyperinflation. Presence of fetal tissue matter, including epithelia and hair, in the maternal intravascular space may also be seenll .t2. Immunohistochemistry is of

UWOMJ 74(1) 2005 21

considerable utility in diagnosing cases of APE by detecting particulates of fetal origin in the pulmonary vasculature.
Specifically, high and low molecular weight cytokeratins, alcian
blue PAS at pH 2.5, Attwood, Movat connective tissue, and oil red
0 stains can detect hallmarks of APE, including fetal squamous
epithelia, mucin and lipid dropletsii ,I2. Monoclonal antibody
TKH-2 has been recently shown to detect glycoproteins associated with APEI 2.
Differential Diagnosis of Amniotic Fluid Embolism
The differential diagnosis of APE centers around the circulatory, respiratory, coagulation, and neurologic concerns and
includes: Hypotension/Shock symptoms - Septic shock,
Hemorrhagic shock, Anaphylactic reaction, Myocardial infarction, Cardiac arrhythmias; Respiratory distress - Pulmonary
embolism of other etiology, Pulmonary edema, Complications of
anesthesia, Aspiration; Bleeding disorders - Disseminated
intravascular coagulation, Placental abruption, Uterine rupture,
Uterine atony; Neurological conditions - Eclampsia, Epilepsy,
Cerebrovascular accident, Hypoglycemia I.

MANAGEMENT
Successful management of APE stems from correcting, as
rapidly as possible, the symptoms noted above. Interventions fall
broadly under the categories of respiratory, circulation, coagulation, and fetal concerns.
Respiratory management includes monitoring oxygen saturation, and administering I 00% oxygen through any means.
Intubation may be considered if a more aggressive approach is
warranted and could include positive-pressure venti lation starting
at 5 em H20, increasing at 2 em H20 intervals until reasonable
Pa02 and Sa02 levels are attained14.
The most pressing concern regarding circulation is clearly
the possibility of cardiac arrest, and must be addressed promptly.
Electrocardiographic observation is useful in monitoring for
arrhythrnias9. Delivery of the child also reduces uterine pressure
on the inferior vena cava and should be performed as soon as
essential respiratory and circulatory activity is ensuredl. Volume
replacement consisting of an isotonic crystalloid solution should
be also supplied to maintain a systolic blood pressure of at least
90 mmHg, with a minimum urine output of 25 mL/h indi cating
adequate organ function1 4.
Hemorrhage and coagulation are the final barriers to uccessful recovery and must also be controlled quickly to promote
recovery. Uterine massage may be useful in controlling uterine
bleeding. If massage and normal pharmacological approaches are
unsuccessful , a hysterectomy may be necessitatedl. Blood component or whole transfusion represents first line therapy for correction of coagulopathy and should be administered as soon as
critical respiratory and cardiac events, if present, are under control. Transfusion is dually-effective in this application as it has
been shown to be successful in both correcting maternal coagulopathy as well as directly binding fetal particulatesl .s.
Fetal concerns center primarily around hypoxia and are best
treated by emergency delivery or cesarean if resuscitation of the
mother is unsuccessful.
CONCLUSION
22
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Amniotic fl uid embolism is a rare and often fatal complic~.
.
. kl
cogm· zed on the basts
t10n of pregnancy which must be qUJC Y re
.
of clinical signs and symptoms and managed effectively to proand child. Current
.
mote a favourable outcome for bot h mo th er
.
.
t of cardioresprratory
therapy centers on mtens1ve managemen
'
coagulatory and fetal complications. Recent evidence suggests
that an i~une-mediated response plays a role in AFE's ons~t
. progressiOn.
.
· dt' rected towards this
Current researc h IS
and raptd
anaphylactoid component. More research needs to be done to
understand APE- however current theories may soon lead us to
more effective diagnostic and treatment methods.
REFERENCES
1.
2.
3.
4.

5.
6.
7.

8.
9.
10.

11.

12.

13.
14.

Perozzi KJ, Englert NC. Amniotic fluid embolism: an obstetric emergency. Crit Care Nurse. 2004;24(4):54-61 .
Humphrey A. Princess of Wales: a royal tragedy. Midwives Chron.
1989;102:304-305.
Gilbert MG. Danielson B. Amniotic flu id embolism : decreased mortality in a population-based study. Obstet Gyncol. 1999;93:973-977.
Clark SL, Hankins GDV. Dudley DA , Dildy GA . Porter TF. Amniotic fluid
embolism: analysis of the national registry. Am J Obstet Hyncol.
1995; 172: 1158-1169.
Morgan M. Amniotic fluid embolism. Anaesthesia. 1979;34:20-32.
Tuffnell DJ. Amniotic fluid embolism. Curr Opin Obstet Gynecol.
2003; 15:119-122.
Tram ani G, Valentin S, Robert MO, et al. Amniotic fluid embolism during caesarian section. lnt J Obstet Anesth. 2004;13:271-274.
Bastien JL, Graves JR. Bailey S. Atypical presentation of amniotic fluid
embolism. Anesth Analg. 1998;87: 124-126.
Gei G, Hankin s GDV. Amniotic fluid embolism : an update. Contemp
Ob/Gyn. 2000;45:53-66.
Jam es CF, Feinglass NG. Menke DM. Grin/on SF, Papadimos TJ
Massive amniotic fluid embolism: diagnosis aided by emergency transesophageal echocardiography. /nt JOb Anesth. 2004; 13:279-283.
Marcus BJ. Collins KA. Harley RA . AncillG!y studies in amniotic fluid
embolism : A ca e report and review of the literature. Am J Foren Med
Path . 2005:26(1) :92-95.
Kobaya hi H. Ooi H, Hiro hi H. et a/. Histological diagnosis of amniotic fluid emboli m by monoclonal antibody TKH-2 that recongizes
NeuAC alpha 2-6Gal 'Ac epitope. Hum Pathol. 1997;28:428-433.
Weiner CP The obstetric patient and disseminated intravascular coagulation and amniotic fluid embolism. Clin Perinatal. 1986;13:705-717.
Locksmith GJ Amniotic fluid embolism. Obstet Gynecol Clin North Am.
1999:26:435-444.

Health Promotion

A Review of Current Literature on NuvaRing®, a Contraceptive Vaginal Ring

Michelle Ngo, B.Sc. B.Ed. , Meds 2007

The number of choices for daily and non-daily hormonal methods of contraception are increasing. This aUows
women to choose a contraception method that fits their lifestyle and preferences. The combined oral contraceptive pill is the preferred method of many women and is often used as the standard that new methods are
measured against. However, methods of contraception that do not require once-daily oral administration and
ones that avoid daily fluctuations of hormones may improve compliance. Transdermal hormonal patches,
intra-uterine systems and hormone injections have addressed these preferences of women. One of the newest
products, NuvaRing, has been shown to be an effective, easy-to-use, tolerable and convenient method for hormonal contraception.

· A novel contraceptive vaginal ring, NuvaR.ing®, offers
women another choice for effective and reversible protection
against pregnancy. It is a small, flexible, transparent ring that continuously releases 120 Jlg etonogestrel and 15 Jlg ethinyl estradiol daily. It is worn for 3 weeks followed by a 1 week ring-free
period. NuvaR.ing® has an outer diameter of 54 mm with a crosssection of 4mm. Women are able to insert and remove the ring
with ease. It offers a higher bioavailability than traditional combined oral contraceptive (COC) products since it does not require
gastrointestinal metabolism to exert its effects. NuvaR.ing® provides a constant serum concentration of hormones since it is a
controlled-release formulation; this differs from COC products.
The systemic exposure of ethinyl estradiol is 50% less than that
experienced with COC products that contain 150 mg desogestrel
and 30mg ethinyl estrodiol.
EFFICACY
NuvaRing® has been shown to have a Pearl Index of 0.65
(95% CI 0.24-1.41 ). 1 The pregnancies reported may have been
attributed to misuse of the product like extended ring-free periods. Similarly, another study reported the Pearl Index to be 0.77
(95% CI 0.37-1.40).2 Again, noncompliance and a misunderstanding of how to use the ring were noted. In a review of COC
products, the Pearl Index was found to be 0.04.3 The Pearl Index
is defined as the number of pregnancies per 100 women-years of
exposure.

CYCLE CONTROL
Women need contraception that minimizes irregular bleeding
and allows them to experience a withdrawal bleed so that they can
be reassured they are not pregnant. Extended bleeding or heavy
bleeding may also affect a contraceptive product's acceptability
and user compliance. NuvaR.ing® offers excellent cycle control
compared to COC products. The incidence of irregular bleeding,
defined as any bleeding while the ring is in place, was found to be
<5%.4 This was lower than the incidence of COC groups at 5.438.8%.4 As well, withdrawal bleeding, defined as bleeding when
the ring is not in place, was 98.5% in all cycles.2
OVARIAN FUNCTION AND CERVIX
Reversibility of birth control is an important factor for
women in choosing a method of contraception. A convenient
method should adequately suppress ovarian function during use
and allow quick return of ovarian function once the product is discontinued. Two studies monitored follicular diameter on vaginal
ultrasound as a measure of ovarian function while using the ring.
Maximum follicular diameter was found to be 11 mm during
treatment with NuvaR.ing®, a value comparable to that obtained
with COC products.s Furthermore, only three days of consecutive
NuvaRing® use is required for interference with follicle growth.6
Ovarian suppression after 3 weeks ofNuvaRing® use and 2 1 days
of COC is comparable. 6 The time to ovulation after removal of the
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ring is approximately 19 days.7 There was no data to suggest an
increased risk for cervical abnormalities with use of the
NuvaRing®. t

2.

3.

BLOODWORK
A risk associated with contraceptive hormones is the development of venous thromboembolism. The estrogenic component
is said to be the main cause but the role of the prostegenic component is currently under investigation as well. NuvaRing® does
increase Factor VII levels while COC products decrease it.? There
were no other differences between the two contraceptive methods
in any of the other coagu lation factors measured .B NuvaRing®
causes a higher antithrombin and Protein C activity.? However,
COC products and NuvaRing® are comparable in anticoagulation
and fibrinolytic activity in general. Lipid profiles are influenced
by contraceptive hormones. Estrogen has a favourable effect on
lipid profile while progestin may counteract this effect by virtue
of its androgenicity. Etonogestrel has less affinity for androgen
receptors which may decrease its unfavourable effect on lipids.
NuvaRing® was found to have a minimal effect on lipids with no
changes in total cholesterol and a decrease in triglycerides .9

TOLERABILITY
In comparison to COC products, NuvaRing® has a higher
incidence of vaginal discomfort, vaginitis and ring-related events
such as foreign body sensation, coital problems or expulsion
associated with its use .J The most frequently reported adverse
events were vaginitis (13.7%), leucorrhea (5.3%), and vaginiti s
(5%).1 However, there were few estrogen-related symptoms such
as breast tenderness and nausea. This may be attributable to the
lower dose of ethinyl estradiol as compared to most COC products .2 Mean body weight increase was found to be 0.43 +/- 3.35kg
over 13 cycles of treatment. I

USER ACCEPTABILITY
The NuvaRing® provides continuous contraception without
the daily hassle of taking a pill. It is easy to insert and does not
require the insertion to be performed by a health care profess ional. NuvaRing® costs approximately $25 a month, which i simi lar
to the contraceptive patch but more expensive than COC products. It is important to note that NuvaRing® cannot be used with
certain secondary forms of contraception such as the diaphragm.
It is a non-biodegradabl e product made of ethylene vinylacetate
copolymers and magnesi um stea rate. Few studi es on the toxi city
of these materials when used in contraceptives have been performed to date but no adverse local or systemi c responses have
been seen over extended periods in vivo.x In a user acceptability
study, women responded that they were 96% sati sfied with the
ring after 13 cycles of use, and 97% would recommend the ring. II
94% of partners of women using the ring reported rarely or never
minding that the ring was being used.l o If desired, the ring can be
removed for up to 3 hours at a time for sexual intercourse.
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COME CARE WITH US
IN CAPE BRETON ...

FAMILY MEDICINE
a ca reer challen.ge ... a lifestyle choice
ENJOY TI-lE CHALLENGE
The Cape Breton DtStnct Health Auth onty requires the
servtces o f a full tune Fam.tly Physician fo r the Victoria
Co unty Mem orial HospitaL Located in the scenic village o f
Baddcck, Nova Scotia, Victoria County Mem orial is a busy
rural hospital and o ne of the eight rural , community and
reg1onal hosp1tals that supports the District's integrated
health delivery system . The District also consists of the Cape
Breton Cancer Centre, Rehabilitat ion and Continuing Care
fnci lities, Addiction Se.rvices and Public Health Services. The
hospital serves a popu latton o f approximately 5.500 that
mcreases annually w1th seasonal vtSits of touri sts to Baddeck s.nd
surrounding areas. Each year, Victoria County Memorial bas
about 8,000 vtsits to its Emergency Depru1meot. All candidates
for tlti s pos ition must be certified by the a llege of Frunily
Phys icians of Canada and be eli gible fo r licensure m ova Scoua.

ENJOY THE LIFESTYLE
Located in the heart of Baddeck, Cape Breton Island, Vlct oria County M eruonal is nestled
a lo ng the s hores o f tile beautiful Bras d 'Or Lak~ . lt is surrowlded by spcctacula.r scenery
including nature trails, rivers. world ~c lass golf courses and s ki facilities . Baddec.k: also
prov id es affordable hous ing, respected schools. and a variety of commun ity !Uld
recreatio nal facilities. Baddeck also has a ncb cultural identity and is home to the
Alexander Graham Bell ational Histori c Site nnd Mu seum .
Pleas~
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direct a ppllcnttou s, Includin g C .V. and three references to :

Or. M . A. Na q vl, Medical Director
Cape Onton DbtTicl Henlth Authorll y
1482 George Street, Sydney, NS B1P IP3
Fax : (902) 567-792 1
B-Mai l· naqvim@c bdha.oshealth.ca
Website: www.c bdha.nsbealth.ca

Dr. C. C bow/Dr. R. Gen ge
Ooddeck Fam il y Practice
65 High Stree~ Baddeck,
ova Scotia BOE I BO
Phone : (9 02) 295-3 165

Medicine and the Law

A New Plan for Plan B

Daren Lin, Meds 2007 and Andrea Guerin, Meds 2008

On April 19th, 2005 Health Canada made the Emergency Contraceptive pill, Plan B, to available behind the
counter without a prescription.' A doctor's visit is no longer required and pharmacists can dispense Plan B
after assessing the appropriateness of emergency contraception. The pharmacist is also responsible for providing counseling on the administration and possible contraindications of the medication, and will make
referrals for future reproductive health counseling.2

WHAT IS PLAN B?
According to the World Health Organization, Plan B is the
gold standard in hormonal emergency contraception.3 Plan B
contains two doses of 0.75 mg of levonorgesterol to be taken 12
hours apart. Common side effects include nausea, vomiting,
dizziness and fatigue.3 The use of Plan B results in a pregnancy
rate of only 1.1% - a reduction of 89%. 3
While Plan B can be taken up to 72 hours after unprotected
intercourse or contraception failure , the maximal effectiveness is
within the first 24 hours after intercourse.4 Therefore increasing
accessibility to Plan B is instrumental in reducing the time from
coitus to emergency contraception administration. Over 80 countries have now approved pharmacists to dispense emergency contraceptive products containing progesterone.s
REGULATORY CHANGES IN CANADA
To improve the timely access to Plan B, Health Canada
amended the Food and Drug Regulations to remove Plan B from
Schedule F, a list of substances intended for human use that
require a prescription.6 By allowing the sale of Plan B without a
prescription, the access to the drug is improved.6 This move has
the potential to greatly increase the drug's effectiveness.6 To
remove Plan B from Schedule F, Health Canada reviewed three
decades of studies covering thousands of women and concluded
that no serious or lasting adverse events were associated with
emergency contraception.6 Health Canada also examined the evi-

dence from other countries that allowed easier access to emergency contraception. 6 In these countries, excessive use of emergency contraception (more than three times per year) rarely
occurred.6 This is also supported by a recent study done in British
Columbia, which has permitted Plan B to be available behind the
counter since 2000.7 The incidence of women using emergency
contraceptive greater than three times during the two year study
was only 2.1%.7 Health Canada thus concluded Plan B satisfied
all of the criteria for nonprescription status.6
While Health Canada decides the prescription status, it is the
National Association of Pharmacy Regulatory Authorities
(NAPRA) that determines whether a drug is placed behind or over
the counter.6 NAPRA classified Plan B as a Schedule II drug,
meaning that it will be placed behind the counter. Health Canada
has supported this policy, noting that pharmacists are well-positioned to play a major role in providing contraceptive counseling.6 However, an editorial in the Canadian Medical Association
Journal questioned the need that any professional consultation for
emergency contraception, pointing out that the behind the counter
status of Plan B compromises a woman's privacy, increases cost
with professional fees, and creates a barrier to access in small
towns.s
THE PHARMACIST' S ROLE
Another barrier related to Plan B 's behind the counter status
is that pharmacists can refuse to dispense the drug, an issue of
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important consequences in regions with only one drug store.9 The
conflict between professional obligations and personal moral
beliefs, although familiar for physicians, is new for pharmacists
who believe dispensing emergency contraception is equivalent to
giving abortion.IO
Currently, the NAPRA Code of Ethics requires that if a medication is in conflict with the pharmacist's personal beliefs, the
pharmacist must pre-arrange access to an alternate source that
minimizes inconvenience to the patient.' ' Pharmacists must also
provide their patients with information that is truthful , accurate
and understandable so that the patients are able to make informed
choices about their health care. II
Some pharmacists groups have called for changes to the
Code of Ethics that would add a conscience clause to protect
pharmacists from liability for refusing to perform an act based on
conscience.2,12 A challenge has also been made to the current
guidelines on referral , questioning the appropriateness of requiring pharmacists to refer a patient for the same procedure that s/he
originally objected to in good conscience.I2 Other writers have
pointed out that a pharmacist's democratic right to their own
moral values does not outweigh their fiduciary obligations to
their patients because they have willingly entered their field . 13
A commentary in the New England Journal of Medicine
points out that although the pharmacist declines to dispense Plan
B because he or she believes that the drug ends a life the patient
may not share the pharmacist's beliefs. If the patient does become
pregnant as the result of failure to have timely access to Plan B,
she may then face the question of abortion - a dilemma that
could have been avoided.l3

DIFFERENT DEFINITIONS
At the crux of this controversy is Plan B 's mechani sm of
action. A recent review of the literature concluded that the main
mechanism of Plan B is interference with ovulation. I4 While it
may also alter the endometrium by making it unsuitable for
implantation, 14 a recent study failed to show levonorgestrel alter
endometrial receptivity. IS Crucially, Plan B will not interfere with
an already implanted embryo.l6 Since Plan B does not interfere
with an existing pregnancy and acts prior to implantation, the
Society of Obstetri cians and Gynecologi ts of Canada label Plan
B as a contraceptive, not as an abortifacient. I?
Using these definition s, and 200 I figures from Stati tic
Canada, it has been estimated that emergency contraception has
the potential to prevent most of the I 06,41 8 abortions (including
19,936 among teenagers) performed in Canada every year. Io The
use of behind the counter emergency contraception in British
Columbia has allowed increased use of emergency contraception,
and thus perhaps fewe r abortions. B
However, these definitions are probl ematic for individuals
and groups who hold the belief that life begins at fertilization .2,9,IO Pharmacists who hold this belief f ind Plan B akin to
abortion because Plan B can still interfere with the impl antation
of a fertilized embryo_2,9, IO
In Co lombi a and Chile, whose laws protect human life at the
moment of fertilizati on, emergency contraception like Plan B is
illegaJ.l 8 Under Canadian law, preventing ferti lization or inhibiting impl antation does not compromise the life of a child.I9
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decrease regular contraceptive use.20, The safety and ~otenhal
benefits of Plan B have prompted the Society ofObstetncia~s and
Gynecologists of Canada to lobby for the drug to be sold without
the help of physician or pharmacist.2 Not only would ~ver the
counter status improve access to emergency contraceptiOn, but
also it would allow women to better control their reproductive
health and alleviate some pharmacists of their own moral conflicts with dispensing Plan B.
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"Born to be a Burden":
A dramatic way to educate medical students about the ethics of prenatal
screening
Tim Heerema, Kevin Kuo, Patricia Lee, Raymond Lim, Jeff Rader, Han y Wu, Meds 2005

Since the implementation of a province-wide maternal serum screening (MSS) pilot program by the Ontario
Ministry of Health in 1993, MSS has quickJy become widely accepted in the management of pregnant women
in Ontario, as well as across Canada and other developed countries. Unfortunately, the quick evolution of
MSS into a routine test for pregnant patients has not been accompanied by enough societal debate on the ethical issues surrounding MSS. A review of literature reveals paucity in the discussion of MSS in association
\vith issues of eugenics, disability rights, abortion, choice, and the rights and responsibilities of the pregnant
woman to the fetus, her family, and society. Additionally, healthcare providers have been shown to have poor
knowledge about the sensitivity and specificity ofMSS, and they often fail to provide adequate and non-biased
counseling and education in the provision of MSS to patients. As such, the lack of debate and education about
this seemingly routine but controversial test is unsettling. Thus, an innovative way to stimulate discussion
about MSS and its potential implications to medical students and health professionals is presented.

In 1993, the Ontario Ministry of Health implemented a pilot
project known as Maternal Serum Screening (MSS). Using the
woman's age and three serum markers: a-fetoprotein, human
chorionic gonadotropin, and unconjugated estriol, MSS estimates
the ri sk of having a baby with Down syndrome, an open neural
tube defect (NTD), or Trisomy 18. MSS is a voluntary screening
exam that was intended to all ow women to make informed dec isions about their pregnancy. However, studies have shown that
healthcare providers ofte n fail to indi cate its voluntary nature',
fail to adequately expl ain the purpose of the test and the meaning
of the results2, and often underestimate the fa lse-positi ve rate of
MSS3. In addition, the healthcare provider's attitude towards
abortion often affects the provision of thi s test3. Fina lly, eva luations of the educational material distributed to pati ents indi cate a
lack of consistent, comprehensive, and unbiased informati on
about MS S4. Despite thi s, parti cipati on in the MSS program by
prenatal care providers has been very high in Ontario, with an
estimated 88% of healthcare providers routinely offering it3. The
adoption of MSS as a routine test by the medical community has
blunted societal debate regarding MSS in association with the
issues of eugeni cs, di sability ri ghts, abortion, and the rights and
responsibilities of the pregnant woman to the fetus, her fam ily,
and soc iety. It is imperative that a forum exist to help stimulate
these di scussion s. Medical educators have demonstrated that literatures and theatre6 are effective in provoking thought and stim-
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ul ating di scu ion. A s such, the theatrical piece entitled Born to
Be a Burden was written to address these issues.
Thi pl ay contain four short skits that tackle the subject
from a chronological perspective. By having the skits span past,
present , and future, we hope to show the audience the origins of
the ethi ca l i ue imbedded in MSS and carry them through to the
pos ible futuri stic consequences. Therefore, the intention and
rati ona le of each kit in this play will be discussed .
The f irst skit involve a discussion about eugenics by some
of its mo t prominent supporters from various periods in history.
Most of the dialogues within this skit are unaltered excerpts from
the original authors. This was intended to provide the audience a
fl avour of the way these authors thought and how these thoughts
were influenced by the political, social, and scientific philosophies at the time.
A particularly charged issue arose in the writing of this skit.
"Eugenic " is associated with numerous atrocities committed by
various governments during the 20th century. However, it was
~rucia l to put forth the idea that MSS is a form of negative eugenICS and that eugenics encompasses more than just atrocities.
Eugenics includes the aspirations of philosophers and scientists
and their vision fo r a better society. Plato and Sir Francis Galton
led the charge into the subject, with Dr. John M . MacEachran
concluding. Dr. MacEachran's recounting of the history of eugenics and steri lization in Alberta illustrates that the movement is not

1

merely confined to Nazi Germany.
The next skit focused on how individual beliefs could potentially interfere with the provision of care to a patient. Doctors are
human. Life experiences and relationships alter patterns of thinking, and physicians bear no immunity to individual biases and
opinions regarding ethically-charged issues. Ethics courses in
medical school, however, preach that individual biases must be
left at the door when one enters medicine. Is this "neutrality of
opinion" a reasonable request to make of physicians? Do doctors
succeed in providing "unbiased" information?
Two doctors face a patient in an office setting to provide
information. The subject matter is MSS and the medical conditions for which it screens. Each physician presents data selected
from the medical literature in a factually accurate and seemingly
non-biased fashion . However, when the two physicians simultaneously counsel the patient, it becomes obvious to the audience
that one physician wishes the patient to receive the MSS, while
the other does not. The following is a short excerpt from the skit
to illustrate the style of the script:
Dr. 1: In the un1 ikely event that your baby has a severe form of
NTD, it would be detected by U/S later in your pregnancy, and in the
case of a minor lesion both the MSS and U/S are ineffective.
Dr. 2: The MSS is 90% effective at predicting severe NTDs. Any
minor defect that is detectable can alter our decision of delivery
method or the defect could potentially be treated in utero.
Dr. 1: Any in utero treatments for NTDs are still in the experimental phase.

The hope of the authors was that this skit would force audience members to consider the power of language when presenting
medical topics for patient consideration.
The third play in the series explores the potential impact of
MSS on people currently affected by disease or disability. The
play introduces us to John Watson, a man who is driven to find a
cure for the disease that killed his first love, Cecilia. Unable to
find a cure, he turns to eliminating the disease by screening it out.
However, he begins to question his discovery when he wonders
what this method implies about Cecilia.
It is hoped that this play would stimulate the audience to
think about a few troubling things : What would have happened if
the test had been available before Cecilia had been born? What is
John now saying about the value of Cecilia's life and others like
her by taking this route to "cure" disease? After all , it was Cecilia
who inspired the research in the first place! How does one balance out these considerations against the good done by eliminating such terrible diseases?
In our fourth skit, set sometime in the future, the audience
visits the consequences of a slippery slope approach t•) MSS. The
Canadian Health Minister argues that pre-implantation genetic
diagnosis (PGD) is a logical extension of MSS . Instead of screening for genetic diseases in fetuses , PGD allows "screening" of the
embryo before implantation. Mothers will no longer need to agonize over whether or not to abort a fetus ; the flawed embryo will
never be implanted.
As time passes, PGD becomes as widely accepted as MSS is
today. Subsequent newscasts narrate the potential consequences.
Loss of genetic diversity leaves children vulnerable to a previously innocuous disease. Parental expectations of their "perfect"

children cause a string of teenage suicides. Preference for boys
over girls leads to an unbalancing of the population. The stark
contrast between the potential benefits and risks of allowing our
children to be genetically screened engages the audience to reconsider the original acceptance of MSS .
The intension of weaving together so many short skits was to
expose the audience to the many complicated ethical issues
involved in Maternal Serum Screening. Pro-life and pro-choice
groups clash over the background issue of abortion. Hints of
eugenics may be present in the underlying suggestion that individuals with Down Syndrome, ne ural tube defects, or Trisomy 18
are less valuable to society. MSS as a "standard of care" suggests
that individuals have an obligation to screen for such conditions
because society does not wish to bear the "burden" that such "disabled" lives will inevitably produce. The ongoing search for
genetic causes of disease, coupled with the technology to screen
for such diseases in-utero, suggests that the MSS could easily be
expanded to include other genetic conditions. But who will
decide which conditions are to be included?
MSS has been introduced to our society without an appropriate degree of ethical debate, and this lack of discussion is being
propagated in medical schools. The MSS is often introduced as a
simple test to offer parents more information about their pregnancy. By using drama in medical teaching, the ethical dilemmas
concerning MSS can be explored more deeply. Not only do the
authors and actors of such productions learn about the ethical territory, but audience members are also educated by the production.
Drama can provide the audience with concrete examples of the
potential consequences of MSS , both positive and negative. It
puts faces to abstract concepts and thus can be used to reach a
variety of potential listeners. If done effectively, it can captivate
interest, challenge intellect, and stimulate emotions. Most importantly, when followed by an appropriate forum, drama leads to
discussion .
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Non-Directive Counselling: Rhetoric Or Reality?

David Silver, Meds 2006

"Non-directive counseiJing", with its emphasis on respecti ng a patient's right and ability to make autonomous
choices, is widely regarded as being central to the practice of genetic counselling, particularly in regards to
prenatal screeni ng. Through non-directive counselling, health care professionals endeavour to empower their
patients to make informed and independent decisio ns, based on the respective context of their own life and
free from outside coercion. However, some criticisms of the non-directive approach have been raised within
the medical community. This paper seeks to outline some of these objections and to examine the role of nondirective counselling in patient care.

Unquestionably, prenatal genetic screening has created an
abundance of new and exciting opportunities within the fie ld of
prenatal care. Armed with our ever-expanding array of genetic
tools, it has become relatively easy to screen for and identify an
abundance of different traits and disorders in utero. However,
what is not always so simple is deciding what exactly to do with
that information once it is obtained. From a patient perspective,
genetic screening in genera l and prenatal screening in particular
can result in the need to make extremely difficult decisions, and
the need for assistance from health care providers in deci phering
the information presented can be profound.
Understandably, while genetic testing in pregnancy care
holds immense therapeutic potential , these tests have also been
accompanied by a considerable amount of controversy becau e of
potential misuse. Consequently, the med ical community has long
sought to decide how best to emp loy the tools granted by
advancements in genetics appropriate ly and responsibly. With
regards to prenatal genetic screening, ' non-directive counselling'
has become established as a central component of patient care.
Shaped by the medical establishment's long-standing belief in a
patient's right to autonomous choice, ' non-directiveness' dictates
that a provider's obligation is to empower their patient to make
informed and independent decisions, free of coercion.
However, despite its seemingly widespread acceptance as a
central tenet of genetic counselling, the true value of non-direc-
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tive counse lling has been ca ll ed into question by some.
Increasingly, members of the medical community have wondered
openly whether the concept of non-directiveness is more rhetoric
than reality, while at the same time going so far as to even question whether non-directive counselling is ever truly possible. This
paper intends to examine some of the objections and criticisms
ra ised with regard to non-directive counselling and to examine
it role as a fundamentally patient-centred approach.

NEUTRALITY: IMPOSSIBLE?
Despite the best efforts of non-directive counselling to assert
objectivity and neutral ity, both research and anecdotal evidence
uggests that thi s is often not the case. This occurs for a vatiety of
reasons, not least among them being that it is often easier said
than done for a counsell or to absolutely suppress his or her own
feelings and/or biases while counselling. Although they might
make every possible effort to maintain neutrality, many counsellors admit to occasionally fa lling short of thi goal, whether
through subtly expressed opinions, or even unconsciously
through more subtle messages conveyed via body language or
tone of v01ce. 1,2 Some studies have further shown that whi le the
principle of non-directiveness is embraced by professional bodies, at least throughout the Western world, how it is actually
employed and to what degree can vary markedly fro m location to
location. 2

The difficulty ofnon-directiveness has also been attributed to
the inherent structure of the patient-counsellor encounter. Several
commentators propose that an apparent conflict of interest exists
in the attempt to uphold a sincerely non-directive methodology
while at the same time working towards preventing a given disorder. Along those lines, Clarke contends that "an offer of prenatal
diagnosis implies a recommendation to accept that offer, which in
turn entails a tacit recommendation to terminate a pregnancy if it
is found to show any abnormality."3 Upon receiving the potentially traumatic news that their baby is "abnormal", many patients
simply do not hear anything else, making it difficult - if not
impossible - for a counsellor to present all options on equal footing. Other outlets have supported similar views, arguing that
while the options for medical treatment are typically presented in
a descriptive manner, patients often understand them in a normative sense as well. Essentially, the offer of " medical treatment" is
not simply understood as providing an objective description of
what is wrong with the patient or their baby and what their
options are, but also as what should be done to treat their condition.4
SPECIAL PATIENT-PROVIDER RELATIONSHIPS

The special challenges of the relationship between a patient
and their primary care provider have also been cited as complicating a counsellor's ability to provide truly non-directive counselling. While counselling is often performed by counsellors who
do not have a past professional relationship with the patient, it is
very common for patients to consult their family doctor, for
example, when faced with such difficult decisions. Though the
previous establishment of trust, rapport, and a good working relationship may be beneficial in some ways, it may also result in the
patient becoming more inclined to simply rely on their family
doctor's advice unquestioningly. Of course, the opposite may be
x true in certain situations as well-patients may only be able to
achieve true empowerment once they feel that their doctor is able
~ to appreciate the wider context of their life. Yet as Evans & Britt
• point out, "it is logical to hypothesize that the longer the prior
association of practitioner and patient, the greater the threat to
patient autonomy".! Whereas the power differential between
patient and provider is of critical importance to questions of
patient autonomy, in situations where a level of trust is already
strongly entrenched, the potential for physician directiveness (and
thus a betrayal of patient autonomy) is that much greater.
PROVIDERS' OBJECTIONS

Regardless of whether non-directiveness is truly attainable or
not, some members of the medical community have questioned
whether it is even an appropriate ideal to strive for in all cases.
Notably, some commentators have argued that occasionally, recognizing and respecting a patient's autonomy should not be the
primary goal. Whereas respect for a patient's autonomy requires
the practitioner to provide information and enable informed
choice, the principle of beneficence might require the practitioner to protect the patient from making decisions that may cause
them distress or harm in the future . If the doctor's role is considered to include both the principles of beneficence and respect for
autonomy, it follows that in certain cases counsellors might be

justified in abandoning purely non-directive techniques and
attempting to persuade patients to reconsider thei r decisions for
the patient 's own benefit S
Similarly, many counsellors have at times expressed di sfavour with pure non-directive counselling due to its restrictions
against insuring that those counselled are fully aware of the moral
consequences of their deci sions. In his exploration of the value of
non-directiveness in genetic coun selling, Clarke questions
whether the medical profession has " fled so far from medical
paternalism that we deny ethical responsibility for our professional activities?" Clarke further expresses resentment at "being
obliged, as I often feel that I am , to be economical with the truth
in discussions with familie s" in certain situations in order to avoid
adding to feelings of sadness and guilt.3 For Clarke and others,
non-directiveness can at times amount to merely 'passing the
buck' by shirking moral and professional responsibilities at a time
when patients face already incredibly difficult choices and might
need a counsellor's experience and expertise most.
NOT SHARED CONCERNS?

Conversely, it might not be surprising to observe that in many
cases the principles of non-directive counselling are not valued
particularly highly by the very people whose rights it seeks to protect. While the medical profession itself holds up issues such as
non-directive counselling, privacy, and informed consent as items
of utmost importance, studies of the public 's opinions regarding
genetic counselling highlight entirely different concerns.
Specifically, such studies indicate that while patients do not wish
to be expressly told what to do, they do expect to be given some
guidance from their health care providers and not simply information and facts alone. 6 Additionally, many consumers of genetic services believe that if asked, providers should offer their opinions of what they would do if in the same situation.
SUMMARY

As physicians and counsellors, it is important to remain
aware of the fact that the context of every patient's life is necessarily different from one 's own, and that the ideas and assumptions that shape one's own world view do not necessarily apply to
someone else's. It is our responsibility as physician-counsellors to
recognize and respect that context from which the patient has
been shaped, to do our best to assist our patients to assess their
own situations as completely as they can, and finally, to empower them to act accordingly. Granted, it is difficult - maybe even
unrealistic - to imagine that all obstacles can be overcome in
order to achieve true neutrality; as stated above, it is rare that a
practitioner can remove him/herself and his/her opinions so completely from the decision making process so as to grant patients
absolute autonomy. As expressed by Evans & Britt, true neutrality is "an ideal to be striven towards rather than an actuality to be
achieved". I Clearly, though it remains widely accepted as a central pillar of genetic counselling, non-directive counselling is by
no means free from difficulties and complications. However, to
admit such a reality should by no means diminish efforts to
achieve the goals of non-directiveness.
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The Experience of Infertility For Women From a Psychological and Social
Perspective

Shirley Chow, Meds 2006

For as long as men and women have been procreating there have been those that have experienced infertility.
Infertility, defined as the inability for a couple to conceive after 12 or more months of regular intercourse
without contraception, can be a significant life crisis for a couple who is planning to start a family. Because
this can be extremely devastating for couples of childbearing age, there is an urgent need for health care
providers to respond to the suffering of infertility patients and to interpret the personal meaning of the experience from an infertile person's perspective. Not only is infertility a medical and physiological state for the
individual, it is also a significant psychological state conditioned by social realities. The focus of this paper is
to promote a greater understanding of how women, desiring children, perceive, react to, and cope with their
inability to conceive, to the end that health care workers may be able to provide support and guidance to help
these women.

Queen Mary of England, daughter of Henry VIII and
Katherine of Aragon, inherited the throne, with one of her most
important goals the birth of a child who might succeed her.
Though she would convince herself she was pregnant, once suffering from a "phantom pregnancy" wherein she gained the requisite weight, stopped menstruating, and suffered with morning
sickness, she was never able to conceive. ' Indeed her " phantom
pregnancy" was subsequently attributed to a tumour in her stomach which, combined with the lack of a menstrual cycle and her
own fervent prayers, made her believe she was pregnant. The
humiliating and heartbreaking realization that she could not have
a child is viewed by contemporary historians as the greatest life
tragedy of Mary "the Barren Queen" of England.
Queen Mary's anguish surrounding her infertility is not
unique to her. Many women have had to cope with infertility
throughout the ages. Although infertility can seem like a very
individual and personal struggle, it is important for women to
know that they are not alone. Today, it is estimated that 10% to
20% of couples will be unable to conceive after one year of
actively attempting to become pregnant.2 A great need exists for
health care providers to interpret the personal meaning of the
experience from an infertile woman's perspective and to respond
to their suffering compassionately.

CURRENT EXPERIENCES OF INFERTILITY
Recent census statistics indicate that a family composed of a

married man and woman and their child(ren) continues to be a
norm in American society.s In Canada, the desire to have and
raise a family has been described as "the most basic and shared
human dream".6 Many women expect to bear a child, and the
decision whether or not to have children is described as a conscious, ongoing consideration for a woman entering adulthood,
integrally linked to her developing life plans.4 The norms of society portray parenthood as a desirable and/or inevitable part of life,
and create a social structure in which childless women are considered an unenviable social anomaly. Despite 30% to 40% of infertility cases being caused by a male factor, studies suggest that
infertility is a more stressful experience for women than for their
male partners.2,3 Regardless of whether the infertility is a result of
a medical problem or some unknown factors, this failure to fulfill
the parenthood role can be detrimental to a women 's personal
identity and result in a myriad of negative psychological states.
The state of feeling " powerless" comes from a loss of control. This feeling extends beyond a woman 's physical body. An
infertile woman may feel a loss of control with respect to her relationships with others, to planning for her future and planning her
family, and to the basic exercise of freedom of choice over her fertility.? As one woman who was unsuccessful with fertility treatments noted:

"It would be one thing if I had decided I didn 't want children,
but the fa ct that I have no control over it, that I've don e all
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the medical interventions, and still have no control. I think
that s probably the most negative thing-the feeling of helplessness."?
In our society, infertile women become stigmatized because
they are unable to conceive. In one study of 71 women, nearly all
of the women were able to provide detailed accounts of negative
responses to their infertility from close family members or
friends , as well as from acquaintances and strangers.s These
women developed negative se lf-perceptions that led them to feel
alienated and isolated from ociety. In a related study by
Sandelowski and Jones, women felt "forced to tell and explain"
their chi ldless state, and to hide their negative feelings in order to
sustai n social relationships (e.g. attend a baby shower for a friend
or ignore insensitive comments). Infertile women also constrai ned or excluded themselves from interactions with others
because of their infertility.9 The e women also felt pressured to
receive inappropriate information or support, such as pitying
comments and "unscientific advice" like "why don't you relax or
take a vacation, then you ' II get pregnant".to Societal behavior surrounding parenthood and reactions to infertility contribute to the
devastating emotional distres experienced by infertile individuals.
Infertile women who have their hopes of bearing chi ldren
shattered can also become clini ca lly depressed. In a qualitative
de criptive study of 25 women who were infertile due to medi cal
or unknown problems, a prevalent theme were feelings of inadequacy.? The pattern of depress ive symptoms associated with
inferti lity is well documented, and occurs most commonly in a
cyclical pattern of hope at the possibility of conception and
despair with the onset of men es.tt Months of this habitual di sappointment can eventually lead to chronic depression. Studies
have shown that infertility depression leve ls in woman can rival
those of cancer patients.t 2 It has also been observed that infertile
women have used coping methods of avoidance to deal with their
stressors. Avoidance-coping strategies may temporarily serve to
offset feelings of di stress by helping women ignore the issue,
especially if they have unsupportive ocial networks. But th e e
strategies can also be maladaptive by inhibiting women from processing the meaning of the negative life event. For instance,
women in the study who employed more avoidance-coping strategies had greater negative emotional fee lings (i.e., greater depre sion, greater overa ll psychological di tress, and lower self-esteem) .

ROLE OF THE HEALTH CARE PROVIDER
Given the psychological pain and grief inferti le women experience and the strained relationships that can occur, health care
providers need to respond and offer guidance. In addition to providing factual information on physiological causes and treatments
of infertility, they can also facilitate a conscious awareness of the
ideological pressures and the negative self-perceptions that lead
to feelings of powerlessness and stigma associated with infertility. With the increased understanding of their stigmatized situation,
infertile women are empowered to take more control of thei r lives
by considering alternative li fe choices and other options for parenthood, and to better understand how to cope with their situation.
Health care providers can also acknow ledge depression a a
risk factor associated with unsupportive soc ial interactions, and
that some level of depress ion is natu ral and appropriate in the
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mourning process of such a great loss.n
Infertile women should also be encouraged to take a m?re
proactive approach rather than coping by avoidance strate~tes.
These approaches could include information seeking or emo~wn
al processing activities such as attending support groups and JOUrnal writing.t 4
.
A discussion on the psychological and social expenence. of
infertility of women would not be complete without ex~lonng
their desire for inferti lity treatment. The desire to have a chtld and
the hope that a medical treatment will successfully lead to pregnancy can motivate women to continue mfertility treatments
despite low success rates .? Even with the risk of draining all
financial resources on medical treatments such as in vitro fertilization (IVF), and the emotional and physical risks associated
with treatment, many women still seek medical solutions.4 This
drive to seek treatment at any cost may be due to a societal philosophy that doing ' nothing ' is akin to failure to take responsible
action, whereas doing 'something ' is viewed as leading to the betterment of a given situation . Therefore many women view the
treatment risks as a nece sary sacrifice and a by-product of persistence.4 When societal views of risk and responsibility are
teamed with women' per istence in the pursuit of pregnancy,
medical treatment may be taken to extremes. Thus, health care
providers, especially tho e involved with reproductive technologies, must educate infertile women to foster realistic expectations
about potential outcomes of treatment options.

COPING WITH INFERTILITY
The experience of infertility can ultimately be a transformational proces from the initial emotional distress to acceptmg and
coping with the diagno i . Acknowledging the emotional frustration and despair infertile women experience helps to prevent
women from inappropriately blaming personal inadequacies for
infertility for which there i most likely no responsibility or from
inappropriately equating the inability to bear or carry a child with
the inability to parenti S With time, meaningful reflection, and
coun elmg, infertile women may begin to accept the reality of
being unable to bear children and redirect their focus to seek
alternative solutions to meaningfully fulfill the role of motherhood. A one woman reported:
"I appreciated being told a definite diagnosis [and prognosis} becau e then I realized that pregnancy wasn't important,
it was the parenting that wa important to me, and we put
ourselves on an adoption list". 7

CONCLUSION
Th~ psychosoci.al experience of infertile women may commo~ly mclud~ .feelmgs of powerlessness, stigmatization from
society, and chmcal depres ion. Guidance and assistance by com· a s uppo rt tve
. envi·
petent health care
. profe sionals optima11y m
ronment can asstst women to interpret their reactions t th d . _
·
d
·
o e tag
· th etr
·
nosts, to ea 1 wtth feelings of inadequacy, and to regam
sense of purpose.
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Perinatal Care for Adult Survivors of Child Sexual Abuse

Nelvia Van Dorp, B.Sc., Meds 2006

Child sexual abuse (CSA) has a sordid history of being
prevalent and underreported, with short and long-term consequences that are variable, complex and poorly understood .
Nevertheless, there is ample evidence to indicate that awareness,
sensitivity and collaborative approaches on the part of care
providers can improve the perinatal experience for women who
were sexually abused in childhood, minimizing retraumatization
risks and empowering women with respect to their own bodie .
The prevalence of child sexual abuse is difficult to determine. Definition and methodological differences in various studies and population surveys complicate the ca lculation, as do the
confounding factors of underreporting and repressed memory.
Girls are more frequently victimized than boys, with one in three
to four women and one in six to eight males reporting sexual
abuse before age 18.5,9 Estimates range from 12-38% of women ,
and as high as 59% with less restrictive definitions that include
touching and exhibitionism.5,9, 10,12, 16 Women with a history of
CSA are at risk of revictimization, with between 15% and 79%
reporting rape in adulthood.14 Notably, women who experienced
CSA were found to be between two and eleven times more likely
to be sexually abused in adulthood than non-abused women.
Since the early 1980's, there has been a significant increase
in efforts to document and explain the sequelae of CSA that affect
women's health throughout the lifespan. There is a wide range of
documented outcomes, which seem to vary in accordance with

36

UWOMJ 74( 1) 2005

the type, duration and timing of the abuse, the perpetrator's relationship with the child, the age and outcome of disclosure experience, other traumatic experiences, the amount and type of support
the chi ld received, and the health of other relationships during the
child's development.l ,4,13 CSA has been linked with post-traumatic stre di order (PTSD) ymptoms that occur consistently,
or present in situations that mimic the setting or experience of
previous abuse, or arise a a result of other triggers .2,4,11 CSA is
also associated with increased treatment in adulthood for other
psychological symptoms, many of which seem to arise from coping mechanisms that become maladaptive later in life.1 2 These
include such symptoms as depression, anxiety, low self-esteem,
suicidal ge ture and attempts, sleep disturbances, personality
disorders, dissociative disorders and panic attacks.t2 There is also
a much higher rate of somatoform disorders and chronic pain
without organic explanation in CSA survivors.9,15 Interpersonal
difficulties of many types including general social functioning,
and particularly couple or spousal interactions including dyspareunia and sexual dysfunction, are also more prevalent in CSA survivors )
Pregnancy and perinatal experiences are often fraught with
difficulty for women who were sexually abused as children. For
some women, internal examinations, cervical smears, childbirth,
and even visits to the dentist trigger memories of CSA experiences and may lead to dissociation, vaginismus, PTSD symptoms

or other difficulties.2,tt There are often parallels to the abuse
experience because of the anatomy involved and the power differential in the relationship, especially if procedures and the reason for doing them are not well understood, if movement is
restricted, or previously traumatized body parts are involved.2,8,tt
Postpartum issues such as risk of depression, concerns about their
ability to protect their own child from abuse and fears about the
'
'cycle of abuse' can also be particularly distressing for mothers
who are CSA survivors. Throughout the childbearing years, there
are particular concerns that caregivers should consider in their
interactions with women who were sexually abused as children.
In order to improve the perinatal care experiences for these
women, practitioners should consider the following recommendations from care providers who have extensive experience in working with women who are CSA survivors:
AWARENESS OF A WOMAN'S ABUSE HISTORY
The first issue is that of awareness of a woman's CSA history, which is best obtained through sensitive screening. Women
rarely disclose information about sexual abuse experiences to
physicians, as indicated in as study of 523 women of whom only
5% of those with an abuse history had ever told a physician.t2
From another study of 164 patients, only 6% had been asked
about sexual abuse (SA), although 68% favoured routine inquiry
by physicians, and 89% felt that physicians could help with problems from SA.6 Friedman and colleagues also found that 74% of
the physicians they surveyed felt that they could help with SArelated problems, and one third felt that screening should be routine, yet screening for SA occurred at only 11 % of initial visits
and 15% of annual visits.6 The abused patients in Friedman's
study were less likely to volunteer information about their CSA
history, and were more likely to favour direct questioning by the
practitioner. Karen Holz asserts that by not asking, the care
provider gives subtle support to the inaccurate belief that the
patient may have - that abuse doesn't matter, should not have
long-term effects, and isn 't worth mentioning.9 Abused women
consulted in qualitative studies say that screening should occur in
a private setting with ensured confidentiality, when the woman is
sitting upright and fully clothed, and be accompanied by reassurance that it is normal for her to have difficulty with aspects of
clinical care, and that efforts will be made to help her cope with
necessary procedures and treatments. 7,9,17 The majority of abused
women favour routine screening, and an even greater proportion
of women endorse routine screening within a safe environment by
a practitioner with adequate training or experience to respond
sensitively when a woman discloses an abuse history.
Simkins' and Holz 's years of experience working with
women taught them that not all abused women disclose their history even when directly asked. Many women do not have conscious memories of their abuse or choose not to disclose initially.s,9,18 They suggest that care providers should suspect a CSA
history in patients with the following behavioural clues - addictions self-destructive tendencies, multiple somatic complaints
with~ut physical cause, poor self esteem, phobias (particularly of
blood, needles, pelvic exams, hospitals, medical procedures,
undressing), sexual dysfunction and inappropriate affect, boundary confusion and anxiety, control issues (including shutting

down labour progress at a level of pain where she can maintain
control), unwillingness to trust authority figures, and flashbacks
or body memories with associated PTSD-type symptoms. Even if
it is not openly acknowledged, a CSA history may have profound
implications in a woman 's life, many of which will influence her
interactions with health care providers.
Building a sensitive, trusting relationship is particularly
important to the quality of perinatal care experiences for women
who have been abused. Sensitivity to the wide-ranging and longterm effects is crucial, as are honesty and clarity in all interactions. Trustworthiness in this setting requires consistency of care
and character, and accessibility within predetermined boundaries.
It is important to allow time for questions, to be empathic, and to
provide positive reinforcement to these women that helps to normalize their experience while acknowledging and addressing
their particular challenges.
A WOMAN WITH A HISTORY OF CSA MAY NEED
MORE EXTENSIVE EDUCATION ABOUT THE PHYSICAL ASPECTS OF PREGNANCY AND CHILDBIRTH
Women with a history of CSA may need more extensive education about the physical aspects of pregnancy and childbirth, as
well as extra encouragement in self-care during pregnancy, since
many respond to their abuse by becoming alienated from or
ambivalent about their bodies.2 A woman 's pregnancy and perinatal period is less likely to be traumatic if she is empowered in
decision making with respect to her body and her care plan.9
Thus, emphasizing choices and informed consent for all procedures is essentiaJ.8,9 Inviting patients to bring their partner, friend
or family member to appointments if they would prefer that to an
office staff witness for procedures may be appreciated. Clear and
thorough explanations - both before and during all procedures
helps women to understand what is happening, and less likely to
feel as though they are being violated while in a defenceless position. Practitioners should inquire about and respect the patient's
wishes regarding the gender of care provider when making a
referral, since choosing a female caregiver is one way survivors
may alleviate their fears .B,t6 Language and word choice can also
trigger abuse memories, particularly paternalistic directives and
the use of slang.2o Postnatal issues for CSA survivors may include
breastfeeding difficulty, interpersonal adjustment issues with
their partner to new roles in the family, fears about the ' cycle of
abuse' , and difficulty trusting their male partners with the
baby.s.tt Parenting classes or groups are often a valuable source
of information and support for these new families . In some cases,
particularly if the abuse memories surface for the first time during the pregnancy or if the implications pose a danger to the
woman or the fetus , it would be advisable to suggest a referral to
a counsellor with expertise in the area of abuse to complement
medical care.
While the challenges abound, pregnancy and childbirth can
also be a very positive and affirming time for CSA survivors, as
it provides an opportunity to learn more about their bodies, take
more control over their physical well-being, and experience their
bodies as capable, strong, and creative. Health care professionals,
particularly those who interact with women throughout their
childbearing years, are in a unique position to build trusting rela-
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tionships that empower women with respect to their bodies. Such
interactions facilitate perinatal experiences which counteract the
abuse outcomes, instead of perpetuating and amplifying the detrimental sequelae of CSA.
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The Motherisk Program - Now at UWO

Gideon Koren, MD, FRCPC, !vey Chair in Molecular Toxicology, UWO

One of the most challenging aspects of drug therapy is the
situation of pregnant women taking medications or exposed to
chemicals. Since the thalidomide disaster it has become apparent
that medications which are safe to the mother may be detrimental
to the developing baby. Common sense may suggest that women
who are pregnant should not use medications or be exposed to
chemicals. Sounds simple, but in fact this situation is very complex in "real life" for the following reasons:
Half of all pregnancies are unplanned; hence millions of
women expose their fetuses to medications.
Often untreated maternal illness may harm both mother and
unborn child.
Many women are addicted to recreational chemicals and cannot discontinue their use.
Millions of women are occupationally exposed to chemicals.
To address the need for information and counseling for pregnant women, we have established in 1985 the Motherisk Program
at the Hospital for Sick Children in Toronto. Presently the
Program counsels up to 200 women and health professionals a
day from coast to coast, as well as from all parts of the world,
(www.motherisk.org). Motherisk is one of very few such programs worldwide and by far the largest.
In addition to counseling, prospective follow-up of pregnancy outcome has led us to the development of the largest database
worldwide and to the publication of more than 400 peer reviewed
scientific papers. In parallel, the 70 team members and students
of Motherisk systematically review all world experience on drugs
and chemicals during pregnancy and breastfeeding.
Lastly, being based in a clinical pharmacology/toxicology
program, Motherisk operates a l~rge research and clinica~ laboratory to study drug exposure dunng pregnancy and lactatiOn. O~r
laboratory pioneered the measurement of drugs of abuse m
neonatal hair and meconium (the first neonatal stools) as a long
term "memory" of the drugs the baby "saw" in utero.

THE IVEY CHAIR
In July 2004 Motherisk arrived at UWO, as I joined the
Faculty of Medicine and Dentistry as the Ivey Chair in Molecular
Toxicology, sharing responsibilities between Toronto and
London. Together with Drs. Doreen Matsui, Michael Reider,
David Freeman, David Knoppert and many others at UWO, we
are establishing an enlarged network that will invite all Canadian
researchers interested in developmental toxicology to work
together.
This will spell exciting new opportunities to interested students at all levels of education at UWO. The lvey Chair has developed the first UWO course in Medical Toxicology to be offered
in September 2005 . We are already participating in both undergraduate and postgraduate training of medical toxicology. This
Chair, together with the new Ivey Chair in Ecohealth research and
other members of the UWO research community, will embark on
an exciting research collaboration in how we poison our environment and are then being adversely affected by it. This issue is near
and dear to all of us, but has only been sparsely addressed.
Human Toxicology, related to medicinal drugs or from environmental chemicals, is a field that transcends beyond medical
sciences. It should include scientists in geography, biology, engineering and social sciences, to mention a few. The lvey Chair will
facilitate such dialogue, hopefully making UWO a leader in how
to ensure safer use of medications and a safer environment.

The contact information for the Ivey Chair is:
rnrouleau@uwo .ca
Tel: (519) 661-3128
Room M242D
Medical Science Building
For the Vision and detailed plan of the Ivey Chair please visit
www.med .uwo .ca/MolecularToxicology/Thelvey-Chair-inMolecular-Toxicology.

UWOMJ 74(1) 2005 39

Ocular Manifestations of Pre-eclampsia

Chetna Tailor, Meds 2004

Pre-eclampsia is an acute condition of pregnancy characterized by hypertension, proteinuria, and non-dependent edema
(hands and face). The condition progresses to eclampsia when
these symptoms are accompanied by grand mal seizures. It is fortunate that neither of these conditions manifest themselves prior
to the third trimester of pregnancy, as delivery of the child is the
only definitive treatment. Approximately I 0% of pre-eclamptic
women will develop the HELPP syndrome (with or without progressing to eclampsia), characterized by hemolysis, elevated liver
enzymes, and low platelets. f.Ithough the cause of pre-eclampsia
is unknown , it is well accepted that the underlying pathophysiologic abnormality resulting in the condition is due to generalized
arteriolar constriction or vasospasm. This, in turn, induces differing degrees of capillary damage, resulting in protein extravasation and hemorrhage. I Almost every organ system can be affected by this vascular abnormality by sustaining damage via hemorrhage and necrosis secondary to arteriolar constriction.2
The visual system is not exempt from being affected by preeclampsia. The condition has been known to affect the conjunctiva, retina, retinal vasculature, choroids, optic nerve, and the visual cortex.2 The most common of these effects manifest as the following symptoms: blurred vision, photopsias (flashing lights),
scotoma, diplopia and blindness. Examination and investigations
of women with pre-eclampsia have found that these symptoms
result from retinal arteriolar abnormalities, serous retinal detachments, ischemic optic neuropathy, and cortical blindness.iii
Ocular findings associated with the HELPP syndrome include
bilateral serous retinal detachments with ye llow-white subretinal
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opacities as well as vitreous hemorrhage ) The mechanisms that
induce these changes, resulting in the above-mentioned visual
symptoms, have not been fully elucidated as of yet. It has been
suggested, however, that retinal changes may be due in part to systemic vascular diseases such as diabetes and chronic hypertension
- comorbidities possessed by many pre-eclamptic or eclamptic
patients. Hormonal changes as well as breakthrough in cerebral
autoregulation have also been suggested as possible contributors
to ocular symptoms in these conditions.4

RETINAL ABNORMALITIES
The most common retinal abnormality found in pre-eclamptic patients is focal arteriolar spasm and narrowing which may be
associated with peripapillary or focal areas of retinal edema.4
Serous retinal detachment occurs in 1% of pre-eclan1ptic
patients and 10% of eclamptic patients.4 In a non-preeclamptic
individual the condition is thought to occur as a result of a defect
in the retinal pign1ent epithelium. This defect leads to focal leakage of fluid from the choriocapillaris which in turn potentiates
serous det~chment of the sensory retina (figure 1 and 2).5 In
patients with severe pre-eclampsia or eclampsia, serous retinal
detachment has been associated with yellowish, opaque retinal
pigment epithelium lesions. It has been theorized that these
lesions result from choroidal ischemia or infarction. Fluorescein
~ngiography in su.ch patients has supported this theory by revealmg that these retmal pigment epithelium lesions correspond to
areas of delaye~ ch.oroid~l filling .6 This theory is further supporte.d by th~ locat10n m ~h1ch most of these retinal pigment epithehum les10ns occur - m the macular and peripapillary regi ons.

Previous studies have suggested that the close proximity of the
macul ar region to the site at which many watershed zones of short
posterior ciliary arteries and vortex veins meet renders it highly
vulnerabl e to ischemic disorders. 6
Hormones, coagu lation, and hemodynamic processes are all
thought to play a part in the pathogenesis of serous retinal detachment.3 Hematologic changes in pre-eclampsia, including hemoconcentration and increased blood viscosity, lead to slowing of
choroidal blood flow. As a result of the structure of the choriocapillaris, there is a rapid deceleration of flow as arterial blood
moves into the vast network of the choriocapillaris. Under the circum tances of the hypercoaguable state associated with pregnancy, there may be a tendency for clots to precipitate in the choriocapillaris inducing choroidal ischemia. Angiospasm or occlusion
of the choroidal arterioles may also occur. Choroidal ischemia
induces ischemic edema, appearing as yellowish, opaque foci in
the retinal pigment epithelium and deep retina. Serous retinal
detachments develop subsequent to abnormal permeability of the
damaged retinal pigment epithelium.6
Although opaque retinal pigment epithelium lesions and
serous retinal detachments are commonly found together, they are
also found in pre-eclamptic patients independent of one another.
It has been suggested that Jess severe ischemia may alter retinal
pigment epithelium permeability, inducing retinal detachment
without subsequent retinal pigment epithelial edema and opacification. However, if there is sufficient ischemia to induce cell
death, retinal detachment may not follow. 6
Retinal pigment epithelial lesions and serous retinal detachments have been reported to resolve within three weeks in
approximately 80% and 98%, respectively, of women with severe
pre-eclampsia and eclampsia.4 There is minimal or no pigmentary
changes after the resolution of lesions in most cases, although
pigmentary mottling, pigment clumping, and changes mimicking
macular dystrophy have occasionally been observed. It is thought
that delay in choroidal filling in most patients is of too short a
duration to induce significant retinal pigment epithelial cell death
and subsequent scarring.6

CORTICAL BLINDNESS
Blindness as a visual symptom of pre-eclampsia or eclampsia has recently been studied in greater detail. Historically, blindness was thought to have resulted from retinal abnormalities
including edema, vascular changes, and detachment. More
recently, case reports have emphasized cortical blindness, which
is characterized by intact pupillary light reflexes and normal ophthalmoscopic findings .? Current studies correlating neuroimaging and post-mortem pathological findings have shown that transient cortical blindness results from petechial hemorrhages and
focal edema in the occipital cortex. Transient scotomas have also
been shown to result from these changes in the occipital cortex.?
Most cases of pre-eclamptic blindness are now attributed to
changes in the occipital cortex. 4
Until recently, the exact mechanism behind the causation of
cortical blindness was unknown; however, it was postulated to
have occurred from either 1) cerebral vasospasm with ischemic
injury, arteriolar necrosis, and cytotoxic ~dema, or 2} in~reased
capillary permeability with leakage of flmd and protems mto the

surrounding tissues resulting in va ogenic edema.s A recent case
report of a pre-eclamptic woman who had suffered from transient
blindness reported that the use of single-photon-emission CT
revealed that the cortical blindness resulted from vasogenic
edema with selective hyperperfusion of the posterior cerebral circu lation.&
Previous studies have found that the posterior cerebral circulation contains fewer synapses with the sympathetic nervous system than does the anterior cerebral circulation, which could make
the former more susceptible to breakthrough of autoregulation (a
suggested mechani m of cortical blindness).
Two possible mechanisms by which cerebral autoregulation
may be overcome by severe hypertension have been suggested.
The first is overregulation, in which severe cerebral vasoconstriction leads to the lesions seen. The second theory is of breakthrough , which proposes that there is a loss of cerebral vascular
regulation with resultant dilatation leading to focal vasogenic
edema. This mechanism is supported by the fact that symptoms
and neuroimaging findings are concentrated in the region of the
posterior circulation (which is more susceptible to breakthrough
of autoregulation). 9
Cortical blindness due to pre-eclampsia or eclampsia is
almost always a transient phenomenon with reports of blindness
lasting 4 hours to 8 days.4

CONCLUSION
Pre-eclampsia and eclampsia are associated with an increased
incidence of a number of visual changes, including serous retinal
detachment and blindness. Most of these changes have no specific treatment in lieu of inducing labour (most di sturbances resolve
postpartum). During the careful monitoring of such a patient by
an obstetrician, the patient 's visual activity and fundi should also
be evaluated. If visual compromise is detected, the patient should
be referred to an ophtalmologist for further evaluation. 2
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Maternal Hypothyroidism in Pregnancy: The Neurodevelopmental
Manifestations in the Offspring

Nata lie Kotowycz, Meds 2005

Thyroid hormones are critical in regulating growth, development and metabolic rate. They are also implicated
in embryogenesis, fetal maturation and neurodevelopment. Recent studies have examined the clinical manifestations of a lack of thyroid hormone in pregnancy on infant and childhood neurodevelopment. Thyroid hormone deficiency in pregnancy has been implicated in delayed psychomotor development, altered rates of information processing as well as lower IQ in the offspring. This article reviews some of the critical studies that have
examined the neurocognitive manifestations of a lack of thyroid hormone in pregnancy. It highlights the importance of carefully monitoring preexisting thyroid conditions when treating pregnant women and also emphasizes the significance of thoroughly investigating suspected cases of thyroid dysfunction in pregnant women.

The thyroid gland is responsible for the production of two
hormones, triiodothyronine (T3) and thyroxine (T4). These hormones play a pivotal ro le in regulating metabolic rate, growth and
development. They have also been found to be of chi ef importance in embryogenesis as well as in fetal maturati on and neurodevelopment.'
The fetal thyroid gland can be recognized by 7 weeks gestation and it begins sequestering iodine and synthesizing T4 by 810 weeks. The T 4 however is not secreted until 18 to 20 weeks.'
In contrast, T3 and TSH production and secretion are noted by 12
weeks.2 It is because the T4 is not secreted until the 18th to 20th
week of pregnancy that the fetus relies on the passage of maternal thyroid hormone through the placenta. It is interesting to note
that human coelomic fl uid has been found to contain maternal T4
as early as the fourt h week of gestation.J Fetal development is
therefore intricately related to the avai lability and pl acental passage of maternal thyroid hormone.
Although maternal thyroid hormone levels may fluctuate to
some extent through the course of a pregnancy, the body seeks to
keep them within a narrow range. Nevertheless, 2.5% of pregnancies are associated with mild maternal hypothyroidism, which
is characterized by an elevated serum TSH.4 Uncontro lled
hypothyroidism in pregnancy is comparatively rare, but it is associated with serious complications including low birth weight,
preeclampsia as well as an increased risk of spontaneous mi scar-
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riage and perinatal mortality.s In view of the fact that fetal development is in part dependent on maternal thyroid hormones,
maternal thyroid defi ciency is also manifested by neurological
and developmental delays during infancy and childhood. It is for
these reasons that physicians must recognize the significance of
periodic thyroid hormone screening in pregnant women with a
positive family history of thyroid disease, goiter, nodules or thyroid conditions. The foll owing is a synopsis of various studies that
have exam ined the specif ic manifestations of maternal hypothyroidjsm in pregnancy on infant and child neurodevelopment. A
primary focus is placed on the role of thyroid hormones in psychomotor development, information processing, and IQ.
In 1999, a study conducted by Pop et al. examined 220 children at 10 months of age using the Bayley Psychomotor
Deve lopmental Index.6 All of the children in the study were born
fo llowing uncomplicated pregnancies and at 12 and 32 weeks '
gestation, the mothers had their ff3 , ff4 and TPO antibody status measured. The study found a significant positive correlation
between the infa nt's PDI score at 10 months and maternal serum
ff4 concentration at 12 weeks ' gestation. Appreciably lower
scores on the Bayley Psychomotor Developmental Index were
seen in the infa nts born to mothers who at 10 weeks' gestation
had ff4 levels below the tenth percentile. Evidently, low maternal
ff4 levels in early pregnancy may have detrimental effects on the
infant 's psychomotor development.

An additional study conducted in 1999 evaluated the effect of
intrauterine and neonatal thyroid hormone deficiency on infant
cognitive abilities.7 This study assessed infant attention, learning
and memory. The infants examined in this study suffered from
thyroid hormone deficiency for one of the following reasons:
maternal hypothyroidism, maternal hyperthyroidism with concomitant anti-thyroid treatment, low-risk prematurity and congenital hypothyroidism. Results indicated that sustained attention
and learning at 6 months of age did not differ between the study
group and controls; however, a statistically significant difference
was seen in the area of general attention and reaction time. The
study group was less attentive and had longer reaction times; the
latter signifies an altered rate of information processing in the
infants exposed to thyroid deficiency.
A study conducted by Haddow et a!. examined the relationship between maternal thyroid hormone levels in pregnancy and
subsequent IQ scores in children.s In this study, serum was collected from 25 216 pregnant women and the women were divided into categories based on their serum TSH levels. Forty-seven
women with TSH levels above the 99.7th percentile and 15 with
TSH concentrations between the 98th and 99.6th percentile
agreed to participate in the study. When the children were
between the ages of 7 and 9, they were asked to perform 15 tests
of neuropsychological function and the effects of maternal thyroid status in pregnancy on the children 's developmental scores
were assessed. In particular, the tests examined language, reading, visual-motor performance, attention and intelligence. The
children of hypothyroid mothers performed worse than controls
on all 15 tests. Word discrimination and attention problems were
significantly worse in the study group. More specifically, 37% of
the children born to hypothyroid mothers versus 19% of controls
had attention problems. Most notably, IQ scores were found to be
4 points lower in the study group when compared to controls. On
this note, 15% of the study group versus 5% of controls had IQ
scores less than 85. Similarly, 23% of children born to hypothyroid mothers had learning difficulties at school; this was double
the rate seen in the control group. Evidently, hypothyroidism in
pregnancy is not only associated with problems in psychomotor
development and alterations in information processing but is also
coupled with poorer school performance and lower scores on
intelligence tests.
The physiological and anatomical bases of the behavioral and
intellectual deficits associated with maternal hypothyroidism in
pregnancy are complex. To date, animal studies have shown that
although rats born to hypothyroid mothers have a normal brain
weight, they have abnormalities in brain amino acid metabolism
and in the enzymes of glial and neuronal cells.9 Furthermore,
these rats have decreased dopamine concentrations in the cerebellum pons medulla and cerebral hemispheres; the latter is also
associ;ted with a reduced serotonin concentration. 10 In addition,
the cerebellar cortex has distorted Purkinjie dendritic trees that
are characterized by shorter branchlets and areas of missing
spines. II It is likely that similar pathways and anatomical abnormalities account for the neurodevelopmental delays exhibited in
infants and children born to hypothyroid mothers. A human study
that examined 13 children born with congenital hypothyroidism,
for which early treatment was sought, found that at age 8 EEG

patterns in 5 of the patients were indicative of dysfunction in the
right parietal and left frontal regions.I2 Taken together, these findings suggest that thyroid hormones play a vital role in the development of brain structures and neuro logical pathways, which then
serve as the foundation for learning, behaviour and intelligence.
Physicians need to realize that the effects of maternal
hypothyroidi sm in pregnancy on infant and child neurodevelopment can be detrimental. In May 2002, the American College of
Obstetrici ans and Gynecologists, ACOG, developed a practice
guideline on thyroid di sease and pregnancy. Although the ACOG
believes it is premature to recommend universal hypothyroidism
screening in pregnant women, it feels that screening with a TSH
test is highly warranted in women with a history or symptoms of
thyroid disease. Similarly, pregnant women with a suspected goiter or thyroid nodules should be further evaluated for thyroid dysfunction .IJ Many patients with a hi story of hypothyroidism will
also require increased doses of levothyroxine during pregnancy
and for this reason, in such patients, TSH levels need to be
assessed during each trimester. Physicians need to ensure that a
normal thyrotropin concentration is being maintained and that
any dose adjustments are being made appropriately.I4 Physicians
need to be very attentive to conditions of thyroid dysfunction and
subtle thyroid hormone abnormalities when treating pregnant
women. It is essential that they be aware of the common nature of
thyroid disease in women and the detrimental effects that thyroid
dysfunction can have on the pregnancy itself as well as the subsequent neurodevelopment of the offspring.
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Fetal Surgery: A Review

Sandeep K. Aggarwal, Meds 2006

Fetal surgery is one of the most exciting fields that has emerged in recent decades. Bridging a multitude of
disciplines including obstetrics, paediatrics, surgery, and radiology, the potential of fetal surgery to correct
those diseases that once frustrated clinicians and surgeons is incalculable. Fetal surgery is based on the idea
that diseases and malformations that are too late to treat after birth can be corrected prenatally. Such diseases include diaphragmatic hernia, myelomeningoceles, and hydronephrosis. This article reviews some of the
important motivations and developments for fetal medicine and surgery as well as briefly outlining and discussing two operative techniques: FETENDO and open fetal surgery.

EVOLUTION OF FETAL SURGERY
The fetus has long been shrouded in mystery, inaccessible to
the interventions of the physician. It is only because of developments made in the last few decades of the 20th century that we are
now able to view and treat the fetus as a patient. Perhaps the most
important initial development was the introduction of sonography, which had the advantage over x-rays as being safer and less
invasive to the fetus and mother. Ultrasound allows accurate
imaging of fetal anatomy, which can be measured to determine
normal and abnormal features . In addition, ultrasound allows live
imaging so that the sonographer can see the fetus move parts of
its body or even visualize the beating of the heart. This real-time
technique is also employed in numerous intrauterine procedures
such as amniocentesis, needle puncture, and tissue sampling. This
helped form the basis for prenatal testing to find inherited diseases and malformations which could lead to abortions if the disease was serious enough or relief if the test was negative. That
was therefore the crux of the matter: technology had allowed
'
'
physicians
to detect
many prenatal diseases, but beyond the ability to administer drugs and hormones to treat diseases like congenital hypothyroidism, they remained powerless to treat anatomic defects in utero 1•
The reason treatment in utero was so important came from the
work of neonatologists and surgeons who studied the pathophysiology of the malformations they saw at birth and followed their

development back into the womb. These physicians were frustrated
in the clinics by newborns with devastating malformations they
could do nothing about. In other words, they felt that whatever
treatment they could provide was too late to be effective, and they
needed to intervene earlier to change the course of the disease.
Human disease models were created in fetal animals and the pathophysiology and effects of in-utero intervention were studied. In
addition, obstetricians and sonographers were refining their techniques to detect and study the development of anatomic malformations using ultrasound. Thus, as these two investigations merged,
the pathophysiology of human fetal disea es such as hydrocephalus, hydronephrosis, diaphragmatic hernia, and nonirnmune
hydrops were defined, and the field of fetal medicine was born2.
During the 1980's and 1990's, new technologies, clinical trials, and techniques were developed at a few elite centres that had
the ability to perform such complicated surgeries. The progression
of fetal surgery as a safe, effective technique remains slow, and
there have been many setbacks. However, there were some firsts
that drove research into the field further. Such milestones included the first successful open fetal surgery in 1983, the first successful repair of a diaphragmatic hernia in 1989, the development
of fe_to~copic technology in 1995, and the first myelomeningocele
repa1r m 1997. Currently, successful fetal interventions have been
made to correct cystadenomatoid malformations of the lung, saccrocygeal teratoma, and neural tube defects3.
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As technologies and techniques advance, the potential to correct more anomalies will increase, but it must be remembered that
it is an experimental technique and still has the potential to do the
fetus a great deal of harm. Furthermore, ethical considerations
must be addressed, underscoring the necessity for proper guidelines to ensure the proper use of such procedures. In any case, the
formation and growth of such professional societies as the
International Fetal Medicine and Surgery Society (IFMSS),
which determine the guidelines for fetal treatment, is evidence
that fetal surgery now has a firm foundation for future growth2.

OPERATIVE METHODS
Fetoscopic Surgery: Fetendo
A minimally invasive technique, fetoscopic surgery has
advantages over open fetal surgery which include the prevention
of preterm labour and altered fetal homeostasis due to the procedure as well as the use of local anesthesia4. Fetoscopic surgery is
based on endoscopic techniques; in other words, to perform a procedure normally done with open surgery using a minimal incision
and hence, less morbidity is likely to occur. Being an endoscopic
technique, fetoscopy has many of the same considerations, such
as the imaging modality, the manner of access, the environment,
and the instruments used. Many of these variables are similar to
conventional endoscopy save for a few alterations and challenges.
For instance, fetoscopy has the added advantage of using two
imaging modalities: the endoscope and ultrasound. Furthermore,
while most endoscopic techniques use a C02 gas-filled environment, this is toxic to the fetus and therefore a fluid environment
is instituted and thus involves a greater adaptation of the endoscopic technique. The complications that can arise from this technique are bleeding from the uterine wall or placenta and rupture
of membranes and amniotic leakages.
The process of minimally invasive fetal surgery without hysterotomy is called FETENDO and can be employed in a plethora
of correctional interventions such as the repair of diaphragmatic
hernias, obstructive uropathies, twin-twin transfusion syndrome,
myelomeningocele, and cleft lip. FETENDO involves less uterine
trauma and irritation and thus minimizes the chance of preterm
labour or severe disruption of fetal homeostasis. As a result of
decreased chance of preterm labour, the use of tocolytics is also
decreased as is subsequent maternal hospital stay and complications due to tocolytics6.
The procedure involves anesthetization of the mother and
fetus with halogenated agents to increase uterine relaxation. The
mother is placed in a modified lithotomy position with her legs
low enough so three surgeons can work from each side.
Ultrasound is used to determine whether the procedure can be performed percutaneously or by maternal laparotomy and uterine
manipulation, depending on the position of fetu s and placenta. It
is also used to find the optimal position to place the trocars. Trocar
placement and their later removal are crucial steps in the surgery,
as incorrect insertion and removal can result in uterine bleeding or
membrane rupture. There are many difficulties associated with
FETENDO, which include the unfamiliar fluid environn1ent, positioning of the fetus during repair, and accurate imaging 7.
Open Fetal Surgery
There have been over 120 open fetal surgical cases in humans,
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and the technique can and has been used to correct many P.renatal
malformations, including those done by FETENDO. As w~th any
open surgical procedure, open fetal surgery via hysterotomy IS associated with an increased risk of preterm labour. In addition, because
open fetal surgery requires the exposure of the fetus to the ope.n
environment, hypothermia and disturbances in fetal homeostasis
may result in increased mortality or morbidity. On the other hand,
open fetal surgery does not have some of the same lirni~ations. as
FETENDO, such as the need for special instruments, the difficulties
with a fluid environment, positioning of the fetus, and irnaging2 .
In general, the procedure involves several steps: hysterotomy,
fetal exposure, correction, closure, and postoperative care.
Halogenated anesthetics, indomethacin, and antibiotics are given
before the surgery. The mother is placed in the supine position
and cardiac and perfusion monitors are placed. A low transverse
abdominal incision exposes the uterus and ultrasound is used to
find the placenta and fetus . The uterus is opened utilizing staples
to preserve homeostasis and prevent membrane rupture. The fetus
is continuously bathed in warm saline as it is exposed and
attached to monitoring devices. Once fetal repair is completed,
absorbable sutures and fibrin glue are used to close the uterus,
and warn1 Ringer's solution is used to replace amniotic fluid 2.

DISCUSSION
The gift that fetal surgery provides for its young patient is &
life without the consequences of devastating malformations that
are difficult to treat after they are born. While the procedure is
still widely experimental, the lessons and complications observed
from initial open fetal surgeries will eventually be used to promote less invasive FETENDO procedures to correct a growing
number of diseases. The transition from open to FETENDO surgeries will depend on further interest and experience, more clinical
trials, and continued technological development. Regardless of
the method, new diseases can be added to the fetal surgeon 's
repertoire only after their pathophysiology has been clearly elucidated in animal models , underscoring the necessity for further
research . Furthermore, while the procedure is an exciting one,
especially to desperate parents eeking a solution, the guidelines
introduced by IFMSS must be considered in each case. Continued
growth of fetal surgery relies upon continued development of
fetoscopic techniques and study of the pathophysiology of fetal
malformations, ri k factors, and outcomes.
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The Next Wave - Medical Education Without Borders

Sh erryn Rambihar, Meds 2005

The devastating tsunami of December 2004 was a reawakening of global consciousness. The images of swirling chaos
impelled us to a tsunami of support worldwide, a global heart
emerging, bringing nations, communities and people together.!
Jeffrey Sachs, director of the Earth Institute at Columbia
University and author of The End of Poverty, speaking about the
unprecedented global response said "a world divided by ethnic
and religious disputes suddenly faced its common humanity - and
common mortality - in a disaster of shocking geographic reach ...
is now united to aid millions of vulnerable people trying to piece
their lives back together in the wake of the devastation."2
By redefining our world, this tsunami has forced us to rethink
our reach. Caring and humanity does not stop at our doorstep. As
future physicians caring for humanity, we now have additional
responsibility for involvement further afield. A tsunami a world
away crashing into our consciousness means the death of distance
and an opportunity and responsibility for a more global thinking
and involvement.
The previous issue of the UWOMJ featured an editorial on
the new subdiscipline of Peace Through Health, elucidating the
unique role which health care workers have in promoting peace
by pursuing health, given the downward spiral of war and disease,
positive symbiosis of peace and health, and superordinate goals
such as altruism and justice which motivate those in our vocation.
Peace through Health looks at the complex systems contributing

to peace and conflict such as social, political, economic and legal
ecosystems, and seeks to find global multi-level interventions for
global problems. Our earliest Peace through Health initiatives at
Western inspired the development of UWO's Global Health
Curriculum, as part of a much larger movement within medicine
and medical education, towards a better ecosystem or complexity
science understanding of global health and global concern, as evidenced in the global heart emerging after the tsunami.
Physicians in Canada are challenged by the changing needs
of a dynamic, pluralistic patient population. Statistics Canada's
new projections for 2017 show that Toronto's ethnic composition
will be over 50% visible "minority," and schools and educational
training programs are talking about the importance of preparing
their graduates with cultural competency skills to thrive and survive in this world.3 Harvard Medical School has developed a cultural competency in women 's health training program to train faculty to teach about providing culturally competent care for minority and underserved women, in collaboration with partner universities and backed by the US Dept of Health and Human Services .
International health issues also affect our clinical practice of medicine, and medical school, the training ground for future physicians, should provide opportunities to acquire the knowledge,
skills and attitudes to better understand and manage our patients'
health. The patient-centred ecosystem model espoused at UWO
reminds us of the multifactorial and complex dynamic influences
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on an individual 's experience of health and disease and an international or global health perspective provides a broader context
within which all these interactions can take place.
While as medical students we are taught to seek optimum
health and quality of life for each patient, in practice our responsibilities extend far beyond the individual. Rudolph Virchow
noted that "medicine is a social science, and politics nothing but
medicine on a grand scale"4 and this becomes our reality in practice. September 11 was a "wake-up call that there was a world out
there full of poverty, injustice and violence which we couldn't
divorce ourselves from ."5 The events beginning Sept, 2003 in a
rural village in China spiraling to the SARS epidemic around the
world taught us that we are not immune to events hundreds of
miles away. Gro Harlem Brundtland, Director General of WHO,
recently said: "In the past, desperate conditions on another continent might cynically be written out of one's memory. The process
of globalization has already made such an option impossible. In
the modem world, bacteria and viruses travel almost as fast as
money. With globalization, a single microbial sea washes all of
humankind. The separation between domestic and international
health problems is no longer usefuJ."6
There is now a moral imperative to educate medical students
about the vast differentials in health between and within countries. North/South inequities in health spending,7 and gross disparities in the global burden of health and disease are only two of
the many important issues impacting health that should now
engage us . The first step towards achieving this is an increased
awareness through education.8 Other important ways to include
international health in medical education include reassigning
global research priorities, fostering a culture of understanding
and social justice amongst medical students, and promoting interdisciplinary approaches to health problems, noting the impact of
socioeconomic inequality on individual and population health .
Issues that are international in origin intimately affect the
Canadian health sector,9 and effective public health approaches
must be both local and global.
"Medical schools should provide both theoretical training
and research opportunities on the health consequences of conflict" states the Hague Appelt! for Peace, adopted in 1999 by the
United Nations. Health Canada 's " Social Accountability - A
Vision for Canadian Medical Schools" IO and recommendations in
the Health Care and Globalization chapter of the Romanow
reportll resonate with the current global discussion within academic and clinical medicine. Exploration of these issues has historically been relegated to extracurricular medical student activitiesl 2 and the medical literature suggests that in-depth in-class
teaching is rarel 3. However, medical students worldwide are leading a transformation to include global issues in the medical curriculum at local, national, and intemationallevels.l4
Schulich UWO Medical School has made important strides
in this movement to harness the idealism and instincts inherent to
young physicians, while improving health worldwide. A studentdriven, interdisciplinary global health curriculum has emerged
from our first Peace through Health involvement and has developed and grown in scope and vision over the past three years.
The Faculty of Medicine and Dentistry began by incorporating a case study highlighting Human Rights, Human Conflict,
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Human Health: a Global Approach to Public Health as part of a
Yr IV Ecosystem Health selective in May, 2002 . Des.igned
Ashifa Jiwa (UWO Meds 2002), this case study, the firSt ?f Its
kind in Canada examined connections between human nghts,
peace building ~nd health care in case-based, interactive modules. IS
To work towards our goal of international health issues spanning the medical undergraduate curriculum, we then looked to
Community Health (formerly Health, Illness and Society), an
interdisciplinary course that extends over the entire four years of
the medical curriculum. Elective lectures and panel discussions
were given on peace-through-health issues to first and second
year students. Patient-Centred Learning was another route used to
address international health issues in our medical undergraduate
curriculum, and students in all four years of medical school working with committees on Gender, Equity, Diversity, Women's
Health and Ecosystem Health, discussed cases of the week and
tried to retain inherent medical aspects while adding extra layers
of social and political context conducive to self-study and smallgroup PCL discussions. Symposia open to interested faculty and
medical students included guest speakers Dr. Joanna SantaBarbara of McMaster School of Medicine and Dept of Peace
Studies, Dr. Graeme MacQueen of the McMaster Institute for
Peace Studies, and Dr. Neil Arya, President of the Physicians for
Global Survival.
Arising out of the overwhelming interest in international
health issues and opportunities, the UWO Global Health Interest
Group strives to coordinate curriculum enhancement with the
many existing extracurricular international health opportunities
within and beyond the medical school community. The UWO
Global Health Interest Group is affiliated with our international
health counterparts at Canadian medical schools, the Canadian
Student University Network for Social and International Health
(SUNSIH) and Physicians for Global Survival Student Network.
Activities are open to the general medical school community, and
medical student at large can choose their degree of involvement
in projects of interest. Activities to date have included a Speaker
Series featuring workshops and talks on topics such as
Challenges in International Women Health, Empowerment in
International Health Development, Rural Health Issues in the
Developing World, educational display and film presentations to
medical tudents on AIDS, Hiroshima, and poverty in India, an
inter-univer ity collaborative project with WarChild teaching
London high school students modules on Health. Human Rights
and Sanctions , and Sexual Violence in Conflict and Genocide and
training teachers within the Thames Valley school board, an international health forum for sharing international health clinical
experiences and exchanges, partnership and fundraising strategies
with medical outreach groups including MedOutreach India,
Medical Student Initiatives in China and Med Outreach Tanzania
organizing a book drive for the Kabul library project and
fundraising for the IFMSA Cote D'Ivoire Medical Student Relief.
These are just a few of the many initiatives of the Global Health
Interest Group, and as interest and participation continues to
grow, so too does leadership capacity and experience for current
and future international health experiences within and beyond
medical school.

?Y

s

It is exciting to be involved with the UWO Global Health
~nteres~ Group at a time when International Health is becoming
mcreasmgly important worldwide. The International Federation
of Medical Students Association (IFMSA) is comprised of students from over 80 countries, and has portfolios addressing
Refugee and Peace Issues, Reproductive Health and AIDS, Public
Health, Clinical Exchanges and Medical Education Projects. In
Sweden at the Karolinska Institute, a full-time five week elective
has become the most popular elective course in the curriculum,
taken by over half of the students. The aim is to teach how socioeconomic, cultural, and environmental factors determine the health
of nations and how the global burden of disease and demographic patterns vary between and within countries. The last 2 weeks of
the course are given in Tanzania, India, or Cuba, where the students are taught by local health professionals, and visit hospitals
and health centres. In the United States, the US-based
International Health Medical Education Consortium (IHMEC)
was founded in 1991 "to foster international medical education
in .. . curriculum, clinical training, career development, and international health education policy." The American Medical
Students Association (AMSA) has developed global health education modules, a comprehensive curriculum in integrative medicine started in 1992 at the University of Arizonal 6 and there are
collaborative international medicine programs between Columbia
University and Ben Gurion University.l7 In the United Kingdom,
MedAct, an organization of health professionals that researches
and lobbies on global health issues, has produced a global health
studies curriculum pack which has been used in several medical
schools already. International Health and Medical Centres introduce global health to undergraduate students, and a BSc in
International Health has been created at University College,
London. IS In the Netherlands, medical faculties of two universities in Amsterdam have recently begun an elective course entitled
"Health and issues of war and peace." l9 Closer to home, the
Association of Canadian Medical Colleges is including a special
session on Global Health issues at the Annual Meeting in May
2005, and medical educators have been interested in learning
about ways to integrate global health issues into medical curricula as seen by presentations of the UWO Global Health initiative at
the Royal College Annual General Meeting and the upcoming
May 2005 Ontario Medical Education Network Research
Symposium. Medical schools may be better able to respond to the
challenges oftheir global-minded students with increased awareness of these issues.
The tsunami was a defining event that changed us forever. It
made us rethink the world, bringing other global isues to our consciousness: the life and death disasters of the poor far away, the
famines in Darfur, violence and starvation in the Congo, the mudslides in British Columbia, flooding and waterborne epidemics in
Guyana, among many others. While as physicians we seek the
best health for our patients, we should also strive for the health of
systems to improve global health and the global state of wellbeing. We are no longer just onlookers from a distance; the tsunami
changed all that. We are now part of the global heart emerging
and can all be advocates for change. It has been inspiring to be a
part of the collective engagement of our medical community here
at Western, introducing global perspectives, and I look forward to

the new wave emerging after the tsunami, of global heart and
medical educati on without borders.
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Leamington District Memorial Hospital, situated on the beautiful shores of Lake Erie, a short
drive south of Wmdsor and Detroit bas immediate openings for:
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Family Physicians
With an Underserviced Area designation, number of Family Physicians are urgently needed.
We have openings also for Family Doctors with an interest in Emergency Medicine.
Through the generosity of the community, the construction of a suite of hospital-based offices
bas been recently completed and is available for Family Physicians who wish to open a new
Family Practice.
The Town of Leamington, located in the southernmost part of the mainland of Canada, enjoys
numerous recreational facilities, easy access to natural areas such as Point Pelee National Park
and Pelee Island, abundant fresh produce, and excellent schools and churches. A balanced
Lifestyle in excellent working conditions make this a wonderful area to practice in.
Please visit our website at:

www.leamingtonbospltal.com

We invite your enquiry to : Dr. R. J. Page MD, C.C.F.P
Chief of Medical Staff
194 Talbot Street, West
Leamington, Ontario. N8H IN9
e-mail rpage@ldmh.org
tel: 1-519-326-2373 ext. 4190

Fax. 1-519-322-5584

FAMILY MEDICINE
MCI • Great Place • Great Team •Join us.
lndjvidual flexibility.
Freedom from administration.
Specialists in-house.
Choice of 27 locations.
Appointment or walk-in.
"...efficient, well organized, great staff ..."
is how our doctors describe the MCI team.

,
In the North, you'll get the
challenge you want in a medical
career and the opportunity to
enjoy what the North has to offer
the adventurous spirit. You'll have
the chance to learn about your
patients' lives, their language and
their culture.

For more information on becoming part
of our health care team, contact:

Our salaries are competitive, and
all positions include a generous
benefits package.

Email: hlthss_recruitment@gov.nt.ca
www.nwtphysicians.ca

Interested physicians must be eligible
to be licensed in the NWT.

Recruitment Officer
Toll Free: 1-877-241-9356
Fax(867)873~634

Interested~

Please contact us.

MCI Medical Clinics Inc.
(~16) 440-4040 ext.433
mcimed.com www.mcimed.com
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Think About Practice Opportunities At
The Pembroke Regional Hospital.
Now Celebrating The Opening Of Its $46 Million Expansion
And Offering A Full Range Of Services Including
CT, Nuclear Medicine, An Expanded ER & ICU,
A New 19-Bed Acute Mental Health Unit,
A New 40-Bed Medical Unit,
Expanded Outpatient Rehabilitation Services And A
22-Bed Inpatient Rehabilitation Unit.
Currently Recruiting A Variety Of Physicians
And Healthcare Professionals.

Songez aux possibilites de pratiquer votre profession
a I'Hopital regional de Pembroke.
Hopital celebre en ce moment l'ouverture de ses locaux eJargis,dont
le coOt s ' eleve a 46 millions de dollars.
D offre une gamme complete de services, y compris : Ia
modensitometrie, Ia medecine nucleaire, un service d'urgence et une
mite de soins intensifs elargis, une nouvelle unite de soins actifs de
1te men tale de 19 lits, un nouveau service de medecine generale de 40
lits, des services accrus de readaptation pour les personnes en
tsultation externe et un service de readaptation de 22 lits destine aux
personnes hospitalisees.
Nous sommes presentemeot a Ia recherche de divers
professioooels de Ia sante.
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Regional Hospital

growth
. .

VISIOn

lifestyle
The Peterborough Regional Health Centre (PRHC) is nestled in
the picturesque Ko w o rtho la kes Region . The Kowo rthos offer a unique
and d ive rse ra nge of natura l wonders, cultura l activities, and countless
destinations to exp lore . W ithin on hour's drive of the GTA , Peterboroug h
is a fa mily-oriented community whe re you con enjoy golfing, booting ,
hor seback rid ing , hiking , an d cycling .
Progressi ng toward s o ur new facil ity wi ll a llow for improved hea lth co re
delivery to the mo re than 300,000 residents o f the reg ion and w il l fulfill o ur
regio na l role w ith space for mo re than 500 bed s and expa nded se rvices.
A new facility w ill provide spa ce for ex panded services a nd staff to serve
the re sidents of the reg ion and to be a centre of excellen ce in the delivery
of comprehen sive and accessi ble hea lth core .
For career opportunities, plea se
visi t ou r website or apply to :

Kevin Kirkpatrick, Recruiter
PETERBOROUGH REGIONAL
HEALTH CENTRE, One Hospital Drive,
Peterborough, ON K9J 7C6
Fax: (705) 876-5015
e-mail: careers@prhc.on.ca
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fE~"''RE

(613) 732-2811/pr@pemgenhos.org/www. pemregbos.org

~BOC

Canada Ltd

BOC Gases is the most global of any industrial gases company 1n the indusry.
We operate in more markets than any other industrial gases company,
contributing to the manufacture of just about every thing produced by man and
machine . The gases we supply help to produce m1crochips. plastics and steel,
freeze food , pump beer, fill light bulbs, test electron m1croscopes. keep rivers
clean and susta1n life for the cntically ill
BOC has manufactunng operations 1n about 50 countries and sales 1n many
others. We have around two million customers World-wide. and we sell them
products rang1ng from a small welding torch nozzle to the worlds b1ggest
nitrogen plant
We serve markets in the automotive. chemicals, petroleum , electroniCS and
semiconductor fabrication sectors We have customers 1n the food processing ,
metals manufacturing , glass, pharmaceuticals, eng1neering fabrication and pulp
and paper industries We sell environmental technolog1es. laser gases. and
safety and industrial safety equipment We have customers including universities , research and development establishments, public utilit1es and medical
facilities of all kinds
To meet their d1verce needs , our engineers des1gn. construct. operate and
maintain air separation units They design and develop gas applications and gas
equipment, and formulate gas mixtures for lasers and other speacial purposes.
They des1gn and install effluent and emission treatment systems and are at the
forefront of developments in applications for CFC-free refngerants
BOC Canada Ltd
5975 Falbourne Street. Un1t 2
Mississauga, Ontario L5R 3W6 Canada
Tel· 905-501-1700
www.bocgases.ca

enrich
your practice

expand
your horizons
Located in sceni c Ottawa, Queensway Carleton Hospital is
a patient and family-centred urban community hos pital.
Providing a broad range of progressive acute care serv ices
to the people of Ottawa and the Ottawa Valley, cornerstone
prog ram s include: Emergency, Childbirth , Geriatrics,
Mental Health , Acute Rehabilitation,
Medical and Surgical Services. With
a strong focus on the future, QCH will
soon be expanding and improving its
setti ng, as a redesign and ex pansion

Q ueensway Carleton
Hospital

of its faci lities are currently underway to meet the needs of
a fast-growi ng community.
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London Hospitals

Our journey toward
renewal of the
London hospitals
continues.

Building Together

~SIJOS
www J,ondonhos.pita Is.ea

What's new •••
• The new $42 million G.A. Huot Surgical Centre and
Diagnostic Imaging Centre at St. Ja;eph's Hospital is under
construction, with an expected completion date of September
2005.
• As a key initiative in the development of a new mental
health care system, St. Joseph's Regional Mental Health Care
is creating new community programs to support successful
home living.
• At LHSC's Victoria Campus the 10-storey shell of the new

Children's Hospital ofWestem Ontario and Grace Donnelly
Women's Health Pavilion was topped off in June 2004. When
it is completed in 2008 the new tower will house women's
and children's programs, as well as acute mental health
programs, laboratory services, and the K.L. Sumner Centre
for Health Learning.
• The Lawson Health Research Institute has completed two
new research facilities: The Victoria Research Laboratories at
Victoria Campus and the Legacy Pavilion, University Campus.

Through the dedicated efforts of physicians, staff and leadership, we are able to sustain excellence in patient care,
research and teaching while we work through this complex, exciting, transformation of London's hospital system.

Committed to providing the best health care possible

Faites carriere dans un h6pital cinq etoiles *****!
Un complexe hospitaller unique et de renommee nattonale, l'hOpltal Montfort est un fotabltssement communautalre
unlversltalre voue a l'excellence. ll se clcwe d'alllalrs en premiere place de tous tes ftabllssements hospltallers de
la prov1nce pour la satisfaction de Ia clientele. Montfort se dlstlngue par son caractere francophone tout en
dessetvant sa clientele dans les deux Lansues offtdelles.

A l'aube de

la plus grande expansion de son histofre, Montfort accueillera un nombre Important de nouveaux
mededns au cours des prochatnes annees. Vous souhaltez fa tre carriere dans un hOpita\ dnq etolles, ta fine
pointe de La technologte 1 Con~ltez regul!erement notre site lntemet pour connaitre les opportunttes, ou
communfquez avec La direction mecltcale.

a

Http:www. hopitalmontfort.com
Pour soumettre votre candidature, veutllez falre parvenlr votre curriculum vitae c\ La Otrectton medtcale, 713
chemin Montreal, Ott;~wa (Ont;~rlo) K1 K OT2 courr1el : rh®montfort.on .ca

JOIGNEZ-VOUS 1 une equtpe dynamfque ayant ~ cceur Les so1ns personnaltWs et empretnts de compassion I
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Important information
for women during midlife.
It's all about estrogen.
From adolescence a woman's estrogen lewishave a familiar cycle. However, at some
point they start to fluctuate and decline causing symptoms associated with midlife - hot
flashes, night sweats and mood swings.
Estrogen Levels from Puber1y lo Menopause

In doctor monitored dinical trials. Promensil was
very successful. In fact. 90% of the women in some dinical
trials diose to continue taking It after the trials had ended'.
Just one daily tablet of Promensil,
standardized to 40 mg, provides eight times as many isoflavones
as the typical North American diet, with no side effects or weight gain.
e!S .....
[lll/11 It 1\ o,rtun mtendf:'d
pour un~:" quatanl <llne nt~ l un•llr

prom ensW

What nature takes away, however, it can also replace.

The natural way to help
restore balance during mldlife.

The natural dietary approach.
In major hea~h studies of Asian and latin women, midlife is a relative non-event'.
Their diets are traditionally rich in isoflavones (natural plant estrogens) obtained through
their consumption of lentils. soy, chick peas and other legumes.
A clinically proven and proprietary formulation. PromensiiN has a specific
ratio of all four important dietary isoflavones, extracted from nature's richest source Australian red dover. This makes the isoflavone content in one tablet of Promensil similar
to that of traditional Asian and Latin diets.

Visit our website -promensil.com
or write to: F.G.P.O. Box 81210,Anc.aster. Ontario L9G 4X1
CLINICAL TRIAL INFORMATION

For a complete package of published clinical trials
:.........
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-CPS

Canada's Trusted Choice

INDICATIONS ARE,

DOCTORS LOVE IT

e-CPS

Instant, Accurate, Up to Date
Launched in June 04, e-CPS is proving highly popular with physicianS---and
with good reason . It's the all-new interactive version of the CPS, and it
provides instant access to all the information needed for informed patient
care. Its close to 3000 Health-Canada approved product monographs
are constantly updated and always current. It also offers an array of
easy-to use tools and resources. To preview e-CPS or subscribe, visit
online at www.pharmacists.ca.

www. pharmacists.ca • 1-800-917-9489

CANADIAN
ASSOCIATION DES
PHARMACISTS PliARMACIENS
ASSOC IATION DU CANADA

